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ABSTRACT 
 
 
 Mammalian inner ear cochlear auditory hair cells (HCs) and adjacent supporting 
cells (SCs) are believed to derive from the same progenitors during development. 
However, unlike SCs of non-mammalian vertebrates, mammalian cochlear SCs cannot be 
converted into functional hair cells (HCs) after damage, thus leading to permanent 
deafness. To entitle mammals with the ability to restore hearing capacity after HC 
damage, we first achieved proliferation of SCs by acute ablation of p27 or Sox2. 
Secondly, we overactivated Notch1 signaling in the mouse inner ear at different 
developmental stages, and found that the ability of Notch signaling in generating new 
HCs declines after birth. Last, we achieved reprogramming of neonatal and juvenile, but 
not adult, SCs into HCs, through ectopically expressing Atoh1 in SCs. Taken together, 
Atoh1 is able to reprogram SCs into HCs, and inactivation of p27 or Sox2 can achieve 
proliferation of SCs. This work builds the foundation for future HC regeneration studies. 
Combining these two manipulations may represent a promising approach to recapitulate 
the cellular events occurring in the process of HC regeneration in non-mammalian 
vertebrates.   
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CHAPTER 1.    INTRODUCTION 
 
 
1.1 Similarity between Hair Cell Development and Regeneration  
 
 
1.1.1 Hair cell regeneration in birds 
 
 The capacity of birds to regenerate auditory hair cells (HCs) from the adjacent 
supporting cells (SCs) was identified about 20 years ago.1 Since that discovery, other 
non-mammalian vertebrates such as fish and amphibians were also found to have HC 
regeneration ability. Briefly, two days after either noise or aminoglycoside antibiotic (i.e. 
genetamicin)-induced HC damage to the birds’ auditory organ, also referred as to basilar 
papilla (BP), the nascent embryonic-like HCs appear in the BP region where HC loss 
occurs. The nascent HCs also become fully differentiated and are functional within 2~4 
weeks when the normal histological pattern is restored and hearing is recovered.2,3  
 
 
1.1.2 Mechanism of avian hair cell regeneration  
 
 There are two proposed molecular mechanisms underlying the HC regeneration 
process in the birds’ BP. The first is direct transdifferentiation in which upon HC 
damage, the neighboring SCs rapidly switch to a HC fate and undergo differentiation to 
HCs without cell division, which contributes to the first regenerated HC pools.4 The 
second is mitotic regeneration which occurs relatively later than the direct 
transdifferentiation. It postulates that SCs first divide and produce daughters which 
further develop into either the HC or SC fate.5,6 Both direct transdifferentiation and 
mitotic regeneration are necessary to restore the normal morphology of the birds’ BP. 
Briefly; the newly regenerated HCs recapitulate the pathway of the normal chick HC 
development.6 These models highlight the promise of manipulating the key 
developmental genes to endow mammals with the capacity to regenerate HCs after 
damage occurs, which normally does not occur. 
 
 
1.2 Key Genes or Signals in Mouse Cochlear Development 
 
 
1.2.1 Histology of mouse cochlea  
 
The mouse cochlea is derived from the ventral part of the otocyst adjacent to the 
hindbrain. The primordial cochlea first appears around embryonic day 11 (E11) and 
finally transforms into a coiled organ with 1.75 turns before birth. The auditory 
epithelium, also referred as organ of Corti, contains two main cell types, hair cells (HCs) 
and supporting cells (SCs) (Figure 1-1). Outside the organ of Corti lies the two 
non-sensory regions, greater epithelium ridge (GER) in the medial side and lesser 
epithelium ridge (LER) in the lateral side. HCs and SCs are believed to derive from the  
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prosensory progenitors in the sensory regions.7 There is one row of inner hair cells 
(IHCs) and three rows of outer hair cells (OHCs). IHCs and OHCs work differently to 
detect sound. The IHCs are the primary mechanosensory cells that are connected to ~90% 
of the cochlear spiral ganglion neurons. The OHCs mainly are the amplifier of the 
coming sound and are innervated by ~10% of the spiral ganglion neurons (SGNs) which 
further replay the hearing information to auditory cortex.  
 
 
1.2.2 Roles of Notch signaling during mouse cochlear development  
 
The Notch signaling pathway in metazoans regulates the short-range 
communication between cells, such as cell death, proliferation and cell fate specification.8 
In mammals, there are four different Notch receptors (Notch1 to Notch4) and different 
Notch ligands (i.e. Jagged1, Jagged2, Dll1 and Dll3).9-12 Gain and loss of function studies 
suggest that Notch1 is the primary receptor expressed in mouse cochlea.13-18 Currently 
Notch1 signaling is assumed to incorporate all Notch signaling activities in mouse 
cochlea. When the ligands bind to Notch1 which then is cleaved, allowing the 
intracellular domain to translocate into the nucleus, where it interacts with Rbp-J, and 
induces activation of different Notch target genes. 
 
Notch1 signaling generally elicits dual but contrasting effects: the first is the 
lateral induction effect.19-22 The lateral induction effect occurs in the developmental 
period when cochlear cells are undergoing rapid proliferation. Among the cochlear cells, 
those with active Notch1 signaling are specified as cochlear progenitors, although the 
detailed mechanism is poorly characterized. After the cochlear progenitor cell pool is 
generated, progenitors will undergo cell fate specification and differentiate into either 
HCs or SCs, mediated by the second lateral inhibition effect of Notch1 signaling.23-29 
Briefly, cells maintaining Notch1 signaling activity develop into SCs, and cells gradually 
losing Notch1 signaling activity become HCs. 
 
Because Notch1 signaling specify the progenitor cells, overactivation of Notch1 
signaling in very early embryonic mouse inner ear non-sensory regions recently is shown 
to generate ectopic HCs.13,15 This provides us with a promising approach to generate new 
HCs after HC damage in mammals. However, it remains elusive whether such an effect 
still can be elicited when Notch1 signaling is overactivated in neonatal or adult mouse 
cochlea. This question is of particular interest in studies of mammalian HC regeneration 
because the majority of the human deafness occurs at postnatal ages from various 
ototoxic factors. Thus, clarifying this question is one of the three goals in my graduate 
dissertation.    
 
 
1.2.3 Roles of Atoh1 in mouse cochlear development  
 
Atoh1, atonal homolog 1 in Drosophila or Math1 in mice, is a basic 
helix-loop-helix (bHLH) transcription factor. We will use Atoh1 hereafter throughout the 
dissertation. It is a proneural gene required in the formation of chordotonal organs and 
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photoreceptors in Drosophila.30,31 In mammals, Atoh1 is expressed in the cerebellum, the 
dorsal neural tube, the intestine, and the inner ear.32-35 
 
During mouse cochlear development, Atoh1 is first expressed around ~E12 in the 
common progenitors for HCs and SCs.36,37 Atoh1 is necessary for specifying the HC 
progenitors, and Atoh1 germ line knockout mice lack HCs in the cochlea.38 An 
antagonistic interaction between Notch1 signaling and Atoh1 has been proposed. Briefly, 
Notch1 signaling can inhibit the transcriptional activity of Atoh1. Overactivation of 
Notch1 signaling in developmental stages (~E13), when cochlear progenitors are about to 
choose their final fate, blocks further formation of HCs. At postnatal day 0 (P0), 
expression of Atoh1 is restricted into HCs and becomes undetectable in SCs.39,40 
Furthermore, Atoh1 expression in HCs is down-regulated dramatically within the first 
postnatal week and becomes undetectable in HCs in P6.39,40  
 
Although the molecular mechanism remains unclear, overexpression of Atoh1 can 
induce ectopic HCs in mouse cochlea in either in vivo or in vitro conditions.40-44 These 
data support that Atoh1 is sufficient in specifying the HC fate. However, it remains 
unknown whether Atoh1 is sufficient to guide the new HCs to differentiate normally. 
This is one of the key questions to be answered in my dissertation. 
 
 
1.2.4 Roles of Sox2 in mouse cochlear development  
 
Sox2 is a transcription factor that carries a DNA-binding high-mobility group 
(HMG) domain and affects gene transcription through collaboration with different 
partners that are specific to cell type or age.45 The embryonic development of the cochlea 
is tightly dependent on Sox2.46-48 Sox2 expression starts at the onset of otocyst 
development and is gradually restricted to different sensory regions of the inner ear.49 In 
the cochlear portion, Sox2 is first expressed in progenitors, and later on its expression is 
gradually decreased and becomes undetectable in HCs, while its expression is maintained 
in SCs.50,51 
 
The exact roles of Sox2 are developmental stage-and cell-context dependent in 
different tissues.52-55 In mouse cochlea, the roles of Sox2 between E9 and E13.5 remain 
poorly understood. Overactivation of Sox2 in cochlear progenitor cells (~E13) inhibits 
HC formation, suggesting the existence of antagonistic interactions between Sox2 and 
Atoh1.48 In addition, Prox1 is a target gene of Sox2 and the initial expression of Prox1 is 
Sox2-depedent, as supported by gain and loss-of-function studies in vitro.48 Although 
Sox2 is expressed in postnatal SCs (both neonatal and adult ages), its role remains 
unknown. We are interested in determining whether Sox2 is a key determinant factor to 
maintain the SC fate and whether the antagonistic interactions (at embryonic ages) 
between Sox2 and Atoh1 remain at postnatal ages. Clarifying this issue is of particular 
interest for both normal cochlear development and HC regeneration study. It is another 
goal of my graduate dissertation. 
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1.2.5 Functions of p27 in mouse cochlear development  
 
 P27Kip1 is a Cip/Kip family cell cycle inhibitory protein. It is also referred as to 
Cdkn1b. We will use p27 throughout the dissertation to define p27Kip1. It primarily 
functions to block cyclin-dependent kinases and block cell cycle progression.56 p27-/- 
germ line knockout mice are larger than their wild type littermates.57-59 Recently, p27 was 
also shown to regulate cell migration and promote tumorigenesis under specific cellular 
conditions.60,61 
 
 During the cochlear development, the primary role of p27 is to drive progenitor 
cells to precisely exit the cell cycle. The wave of turning on p27 initiates at the apical 
turns around E12.5 and migrates to the basal turns around E14.5.62 Following cell cycle 
exit, these progenitors start differentiating in an opposite gradient, from basal to apical 
turns.63 As expected, cochlear progenitor cells in the p27-/- germ line knockout mice 
cannot exit the cell cycle at the correct time and undergo prolonged proliferation, 
resulting in an expanded progenitor cell pool which gives rise to supernumerary HCs and 
SCs.64,65  
 
 When isolated neonatal mouse cochlear SCs are cultured in vitro, p27 expression 
is decreased and SCs proliferate and switch to HCs.66 However, when neonatal cochlear 
explants are cultured and transfected with vectors expressing p27 shRNA, SCs in LER 
regions can proliferate but maintain their intrinsic SC fate. It remains unknown what 
phenotype the SCs inside the organ of Corti will adopt when p27 is deleted. This question 
will be answered in my graduate dissertation. 
 
 
1.3 Mouse Cre/loxP System 
 
The powerful mouse genetic Cre/loxP system enables conditional gain or loss-of-
function studies.67 The Cre-loxP mechanism was first discovered in P1 bacteriophage.68,69 
Cre is a recombinase that catalyzes recombination between two loxP sites. In a Cre 
expressing mouse knock-in or transgenic strain, Cre is controlled by a ubiquitously active 
(i.e. CAG or Rosa26) or tissue specific gene promoter (i.e. Prox1 or Fgfr3 in cochlear 
SCs). To activate the recombinase at different stages, Cre can be fused to the mutated 
ligand-binding domain (LBD) of the estrogen receptor (ER). In the absence of tamoxifen, 
CreER is sequestered in the cytoplasm by the heat shock protein 90 (Hsp90).70 However, 
when tamoxifen is available and binds with the LBD, CreER undergoes a conformational 
change and is released from Hsp90, leading to the translocation of CreER into the 
nucleus. Depending on the orientation and location of the loxP sites, Cre-mediated 
recombination can lead to three different outcomes: inversion, translocation or deletion.71 
Currently, the majority of Cre-loxP systems are used to create a deletion effect for which 
the two loxP sites are designed in the same location and orientation. However, depending 
on the sequence that is deleted in each mutant mouse model, either gain or 
loss-of-function effects can be elicited.  
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1.4 Summary and Hypothesis 
 
 The goal of my graduate dissertation is to provide information for future mammal 
HC regeneration. Due to the similarity between avian HC regeneration and normal HC 
development, the key rationale of our strategy for mammal HC regeneration is to 
reactivate the key HC developmental genes in SCs which are then expected to follow the 
HC differentiation track. We propose three hypotheses: 
 
The first is that isolated cochlear SCs can downregulate p27, proliferate and 
become HCs in vitro. My first hypothesis is that acute inactivation of p27 in postnatal 
mouse cochlear SCs will promote their proliferation and conversion into HCs. 
 
The second is that Atoh1 expression will be derepressed upon acute ablation of 
Sox2 and SCs will be converted into HCs. We proposed this hypothesis because Sox2 
antagonizes Atoh1 during the embryonic mouse cochlear development. Sox2 will be 
acutely deleted in mouse cochlear SCs at different ages in vivo.  
 
The third is that Atoh1 can reprogram postnatal SCs to adopt the HC fate. We 
aimed to achieve direct transdifferentiation from SCs to HCs, similar to what occurs in 
avian SCs when HCs are damaged. Atoh1 will be ectopically induced in the postnatal 
mouse cochlear SCs at different ages in vivo.  
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CHAPTER 2.    P27 IS REQUIRED TO MAINTAIN QUIESCENCE OF 
NEONATAL PILLAR CELLS  
 
 
2.1 Introduction 
 
 When isolated mouse neonatal SCs are cultured in vitro, they can dowregulate 
p27, proliferate and turn on hair cell specific genes, indicating the occurrence of cell fate 
conversion.66 However, whether similar cellular events will occur in the in vivo 
environment remains unclear. Because the p27 germ line knockout mice have defective 
cochlear development during embryonic ages,64,65 the neonatal SCs are not comparable to 
those of the wild type littermates. To bypass defective embryonic development, we took 
advantage of p27 conditional knockout mice. 
 
 To acutely ablate p27 at different postnatal ages, we requested the p27loxp/loxp 
mice72 from the laboratory of Dr. Matthew Fero at the Fred Hutchinson Cancer Research 
Center, and further characterized two different CreER mouse lines Prox1CreER/+ and 
Fgfr3iCreER+.73-75 Prox1CreER/+; p27loxp/loxp mice were treated with tamoxifen at P0 and P1 
to delete p27 at neonatal ages, while Fgfr3iCreER+; p27loxp/loxp mice were treated with 
tamoxifen at P6 and P7, or adult ages (P30) to ablate p27 at juvenile and adult ages. By 
analyzing these genetic mouse models, we will determine whether p27-null SCs 
proliferate and/or become HCs, as it is the case in vitro.66  
 
 
2.2 Materials and Methods 
 
 
2.2.1 Mouse strains  
 
Prox1CreER/+ and p27loxp/loxp mice were kindly provided by Dr. Guillermo Oliver 
and Dr. Matthew Fero and described previously.72,76 Rosa26-EYFPloxp/+ were purchased 
from Jackson Laboratory (USA). All animal work conducted during the course of this 
study was approved by the Institutional Animal Care and Use Committee at St. Jude 
Children's Research Hospital and performed according to NIH guidelines. 
 
 
2.2.2 Histology and immunofluorescence 
 
 Whole embryos at various ages were immersed in 4% paraformaldehyde (PFA) 
overnight at 4°C, after which the whole inner ear was carefully dissected out. For whole 
mount analysis, the whole cochlear duct and corresponding medial spiral ganglion tissues 
were divided into three parts, the basal, middle, and apical turns.  
 
 Both whole mounts and trans-sections were permeabilized at room temperature 
for 1 hour in a solution containing 1% bovine serum albumin and 1% Triton X-100 in 10 
mM phosphate-buffered saline (PBS, pH 7.4). Tissues were then incubated with primary 
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antibodies in blocking solution (1% bovine serum albumin and 0.1% Triton X-100 in 10 
mM PBS) overnight at 4°C, followed by 3 washes for 10 minutes each in 10 mM PBS. 
Then, tissues were incubated with secondary antibodies in the same blocking solution 
overnight at 4°C followed by 3 washes for 10 minutes each in 10 mM PBS. Tissues were 
then incubated for 30 minutes at room temperature in Hoechst 33342 in 10 mM PBS 
(Invitrogen, H3570, 1:1,000), followed by 3 washes for 10 minutes each in 10 mM PBS, 
and finally were mounted in ProLong Gold antifade reagent (Invitrogen, P36934). 
Samples were dried at room temperature for at least 24 hours. 
 
The following primary antibodies were used: anti-myosin-VIIa (rabbit, 1:200, 
Proteus Bioscience, 25-6790) or Alexa Fluor 594-conjugated anti-myosin-VIIa (rabbit, 
1:30, Proteus Bioscience, specific request), anti-myosin-VI (rabbit, 1:200, Proteus 
Bioscience, 25-6791) or Alexa Fluor 647-conjugated anti-myosin VI (rabbit, 1:50, 
Proteus Bioscience, specific request), anti-BrdU (mouse, 1:50, invitrogen, B35131), 
anti-p27(mouse, 1:150, BD Biosciences, 610242), anti-Prox1 (rabbit, Millipore, 1:500, 
AB5475), anti-GFP (rabbit, 1:50, Invitrogen, A-21311) or anti-GFP (chicken, 1:1000, 
Abcam, ab13970), Alexa Fluor 488-conjugated anti-PH3 (rabbit, 1:20, Cell Signaling, 
9708), anti-Sox2 (rabbit, 1:1,000, Millipore, AB5603). We used secondary goat 
anti-rabbit Alexa Fluor 350, 488, 594, and 647 antibodies (1:1,000, Invitrogen, 
A-21068/11036/11037/21245) and goat anti-chicken Alexa Fluor 488 (1:1,000, 
Invitrogen, A-11039). For TSA staining, we used goat anti-mouse HRP conjugated 
secondary antibody (1:100, T20912, Invitrogen).  
 
 
2.2.3 Cell proliferation assay  
 
Mice were given one injection of 5-ethynyl-2’-deoxyuridine (EdU, 20 μg, 
Invitrogen, C10083) and were sacrificed 4 hours later or BrdU (50 mg/kg body weight) 
once every 2 hours for a total of 5 times and were sacrificed 2 hours after the last 
injection. After cardiac perfusion with 10 mM PBS and 4% PFA, tissues for BrdU 
staining were first pretreated with 2N HCl for 25 min at 37°C, followed by three 5 
minutes washes in 0.1 M Tris-HCl (pH 8.0) for neutralization and immunostained as 
described above using an Alexa Fluor 488 or 594 conjugated anti-BrdU antibody (mouse, 
1:20, Invitrogen, A-21303 or 21304).  
 
For EdU staining, we followed a protocol recommended by Invitrogen. For BrdU 
and EdU double staining, mice were injected with BrdU 5 times every two hours at P2, 
followed by EdU injection 48 hours later (P4) and sacrificed 4 hours after EdU injection. 
Cochleae were dissected and immersed directly in methanol/acetic acid (3:1) fixative for 
6 hours at 4°C, followed by BrdU immunostaining (BrdU antibody 1:100 dilution) and 
EdU staining. For BrdU and FISH double staining, we used the same fixation procedure 
with methanol/acetic acid and anti-BrdU antibody (1:100) were used. The BrdU antibody 
does not recognize the BrdU antigen, even though BrdU and EdU share the similar 
structural backbone. 
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2.2.4 Cell counting and cell death 
 
 To account for variability of cell density between different turns of the cochlea, 
the location of each turn was approximated based on the length of the entire cochlear 
duct. We quantified cell numbers in 200 μm length of the apical (75% of the length of the 
cochlear duct, from the hook), middle (50%) and basal (25%) turns using a Zeiss LSM 
510 confocal microscope. A similar approach was used to calculate the percentage of 
p27-null PCs and DCs. To quantify PC and DC number at different ages, DCs, PCs and 
HCs were counted based on location using myosin-VIIa staining to mark HCs. To 
confirm this method, we also counted DCs, PCs and HCs based on location using Sox2 
staining to label SCs. PC and DC numbers were then normalized to HC numbers. SC/HC 
ratios calculated by both methods gave similar results and were thus grouped together. 
 
For cell death measurements, Terminal deoxynucleotidyl transferase dUTP nick 
end labeling (TUNEL) staining was performed according to the protocol provided by the 
Roche Applied Science, 11684795910/12156792910). Prior to TUNEL staining, myosin 
VIIa staining was used for cell type determination.  
 
 
2.2.5 Auditory brainstem response 
 
 Detailed procedures were described previously.77 Briefly, experimental and 
control littermates mice were intraperitoneally anesthetized with Avertin (500 mg/kg 
body weight). Pure tone pips of 4, 6, 12, 16, 32, and 44 kHz were generated by using a 
Tucker Davis Technologies (TDT, Gainsville, FL) work station (System III) running 
SigGen32 software (TDT). The highest sound is 75 dB SPL in our current TDT system. 
At each frequency, the mice were given different sounds gradually from 75 dB SPL to  
0 dB SPL, and the sound threshold was read when no electrophysiological curve was 
detected. 
 
 
2.2.6 Statistical analysis 
 
All data were expressed as mean ± S.E.M. Cell counts were compared using an 
one-way ANOVA followed by a Student’s t test with a Bonferroni correction, and ABR 
thresholds with a two-way ANOVA followed by a Student’s t test with a Bonferroni 
correction.  Statistical analysis was conducted using GraphPad Prism 5.0 Software.  
 
 
2.3 Results 
 
 
2.3.1 p27-null pillar cells leave quiescence and reenter S phase 
 
To acutely inactivate p27 in postnatal PCs and DCs, we treated Prox1CreER/+; 
p27loxp/loxp mice (p27 conditional knockout, CKO) and Prox1+/+; p27loxp/loxp (CTRL) with 
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tamoxifen at P0 and P1. In p27 CKO mice, we found that p27 was progressively deleted 
in both PCs and DCs in the apical turns between P2 and P6, which suggests that it takes a 
few days for endogenous p27 protein to be degraded and eliminated from the cell after 
gene deletion (Figure 2-1A-D). There was also a higher percentage of p27-null DCs 
compared to p27-null PCs at all ages tested, which is consistent with Cre activity detected 
by the reporter assays.73 Additionally, the percentage of apical p27-null PCs and DCs was 
significantly higher than apical Cre+ PCs and DCs detected with the reporter lines 
(Figure 2-1E-F), which further supports the idea that reporter lines somehow 
underestimate Cre activity; however, we cannot exclude that p27 deletion results in 
non-cell autonomous effects.  
 
We next examined cell cycle reentry of p27-null PCs and DCs using incorporation 
of 5-bromo-2´-deoxyuridine (BrdU) or its analogue 5-ethynyl-2´-deoxyuridine (EdU).78 
Surprisingly, of ~130 BrdU+ or EdU+ cells analyzed from P2 to P6, all were PCs, and 
not DCs, based on their location (Figure 2-2A-B). Since the organ of Corti has a precisely 
organized cell arrangement, we were able to distinguish between PCs and DCs relative to 
HCs. Nuclei of PCs are located at the bottom of the triangle area between IHCs and the 
inner most row of OHCs, which correspond to the Tunnel of Corti in the adult cochlea.79 
DC nuclei are underneath, but slightly lateral to nuclei of their corresponding row of 
outer HCs. 
 
To confirm the accuracy of our location distinctions are accurate and that cell 
cycle reentry is exclusive to PCs, we used triple immunostaining with BrdU, p75NGFR (a 
marker expressed in postnatal PCs and Hensen cells but not DCs66 and EGFP in cochleae 
dissected from Prox1CreER/+ ; p27loxp/loxp ; CAG-EGFP+ mice. Since p75NGFR  is expressed 
on the surface of PCs and BrdU labels the nucleus, we used EGFP to trace the entire cell 
boundary of p27Kip1-null cells. This allowed us to accurately determine whether p75NGFR 
and BrdU staining belong to the same cell. All of the ~25 BrdU/EGFP double positive 
cells analyzed were also labeled with p75NGFR, again demonstrating that only p27Kip1-null 
PCs can reenter S phase (Figure 2-2C-F). Additionally, in the ~200 µm apical area 
analyzed, we found several BrdU+ (p27Kip1-null) PCs that were EGFP-negative 
(arrowhead in Figure 2-2D). This might be due to mosaic expression of the CMV/β-actin 
promoter or may indicate that EGFP expression varies depending on cell cycle phase. It 
is also possible that p27Kip1 deletion results in non-cell-autonomous effects.72 
 
We further analyzed ~60 EdU+ PCs from P2 and P4 cochleae and found that all 
were p27Kip1-null, suggesting that cell cycle reentry is cell autonomous (Figure 2-3A-D). 
Because cell cycle reentry of p27Kip1-null PCs in vivo was not synchronized and we only 
injected EdU once or injected BrdU over a period of 10 hours due to toxicity, we were 
not able to determine whether every p27Kip1-null PC reenters the cell cycle. Quantitative 
analysis of BrdU incorporation showed that PC cell cycle reentry initiated at P2, peaked 
at P4 and decreased at P6 (Figure 2-3E-H). 
 
It is quite interesting that while DCs have a higher percentage of Cre active cells 
based on reporter line studies, we did not detect S phase reentry in DCs from P2 to P6. 
We did not analyze after P6 because the precise architecture of organ of Corti was  
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 cochlea occurs in a basal to apical gradient, cells in the basal turn are a few days older 
than those in the apical turn.66 We took advantage of this characteristic to test the 
possibility that DCs may reenter S phase after P6 by analyzing the basal turn of the 
cochlea. Again, we did not find any BrdU+ DCs in any of the basal turns studied (data 
not shown). This result supports the idea that p27-null DCs may not be able to enter S 
phase in the neonatal mouse cochlea. 
 
In addition, we quantified the number of BrdU+ PCs found in the basal turn from 
P2 to P6. There were significantly more BrdU+ PCs in the apical turn at P4 and P6 
compared to basal turns and no statistical difference at P2 (Figure 2-3F-H). The 
difference between apical and basal turns again supports the idea that Prox1 promoter 
activity and thus Cre expression is higher in the apical turn. Because P2 was the earliest 
age when p27-null PCs were observed to enter S phase, one might expect a large 
variation in the number of BrdU+ PCs, which is exactly what we found. This likely 
explains why there was no difference in BrdU+ PCs at P2 between basal and apical turns. 
 
 
2.3.2 p27-null pillar cells complete the cell cycle and generate daughter cells 
 
To determine whether p27-null PCs can progress through the mitosis (M) phase of 
the cell cycle, we used immunostaining for Phospho-Histone H3 (PH3), a marker specific 
for M phase. While there were no PH3+ cells in the control mice, PH3+ PCs were present 
displaying characteristics of prophase, metaphase and anaphase in the organ of Corti of 
p27 CKO mice at P4 (Figure 2-4). When auditory epithelia were analyzed from HC layer 
to SC layer by confocal microscopy, we consistently observed segregated chromosomes 
in a single slice. This suggests that the plane of mitosis was parallel to the luminal surface 
of the auditory epithelium. 
 
The intriguing PH3+ PCs in the p27 CKO mice promoted us to further determine 
whether p27-null PCs can further successfully undergo cytokinesis, enter G1 phase and 
generate new daughter cells, we examined chromosomal duplications of BrdU+ cells 
using the technique of Fluorescent In Situ Hybridization (FISH) with a genomic marker 
(a bacterial artificial chromosome clone containing Gapdh).80 Generally, cells in late S 
phase, G2 and M phase of the cell cycle are tetraploid and should have 4 copies of 
Gapdh, whereas cells in G1 and early S phases are diploid and should only have 2 copies 
of Gapdh; each of which state can be distinguished using FISH.80 At P4, 10 hours after 
the first BrdU injection, we observed 2 of 10 BrdU+ PCs with two FISH dots per 
nucleus, indicating that they had left M phase and reentered G1 phase (Figure 2-4E-H). 
The remaining other 8 BrdU+ PCs had four FISH dots per nucleus, indicating that they 
were either still in late S phase, in G2 phase or in M phase (Figure 2-4I-L). The 2 BrdU+ 
cells with two FISH dots were likely to be cells that were labeled by the first BrdU 
injection. This confirms that p27-null PCs can complete the cell cycle and give rise to 
daughter cells. 
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2.3.3 p27-null daughter cells can further proliferate but continue to express 
supporting cell markers  
 
To determine whether newly born daughter cells can enter S phase, we labeled 
proliferating cells with BrdU (5 injections every 2 hours at P2) followed by a single EdU 
injection 48 hours later (at P4). BrdU and EdU assays do not cross-react.73 We found 
BrdU and EdU double-positive PCs, demonstrating that daughter cells were able to 
reenter S phase (Figure 2-5A-D). Among three mice analyzed at P4, approximately 30-40 
BrdU/EdU double-positive PCs were found in each cochlear duct. In addition, we 
consistently found clusters of BrdU+ cells which suggest that daughter cells could 
continue to proliferate and perhaps were migrating (Figure 2-5B). We also examined the 
total number of apical PCs and DCs relative to the total number of apical HCs at P2, P4 
and P6 and found that the number of PCs continuously increased with age; whereas, the 
number of DCs did not change (Figure 2-5E-F). This further confirms that only p27-null 
PCs reentered the cell cycle and successfully completed multiple cell divisions, which is 
consistent with proliferating SCs in non-mammalian vertebrate HC regeneration.4  
 
We consistently observed that newly formed daughter cells derived from p27-null 
PCs migrated upwards into the HC nuclear layer or even to the surface of the auditory 
epithelium, where p75NGFR staining can be observed (Figure 2-6). This is very similar to 
how avian SCs behave during the HC regeneration process.81,82 After migration, avian 
SCs transdifferentiate into HCs; however, in our p27 CKO model, daughter cells 
continued to express Sox2 and Prox1,50,51,83 two SC markers, suggesting that SC cell fate 
was maintained (Figure 2-7). 
 
Additionally, to trace p27-null PCs, we injected tamoxifen into Prox1CreER/+; 
p27loxp/loxp; Rosa26-EYFPloxp/+ mice at P0 and P1, and analyzed cochlear whole mounts 
double-stained with EYFP and myosin-VI, a HC differentiation marker that is normally 
turned on earlier than myosin-VIIa. No double-positive cells for myosin-VI and EYFP 
were observed at P12-P13 (data not shown) after which cell death occurred. As a 
complementary approach, we injected BrdU daily (from P2 to P12) into p27 CKO mice 
that received tamoxifen injections at P0 and P1. Since endogenous HCs are quiescent, 
any cell double-positive for BrdU and myosin-VI should be generated from proliferating 
p27-null PCs. Again, no such cells were observed at P12. In addition, no ectopic HCs 
were observed between P2 to P15. These three independent lines of evidence support the 
idea that daughter cells of p27-null PCs maintain SC fate and that no newly formed HCs 
were derived from proliferating p27-null PCs in our current mouse model. 
 
 
2.3.4 Endogenous hair cells undergo cell death after P15  
 
There was no evidence of HCs loss in the p27 CKO cochlea at P10, while 
p27-null PCs underwent multiple divisions; however, considerable HC loss was found at 
P15, possibly caused by accumulation of proliferating PCs in the restricted space of the 
organ of Corti. We found that the majority of HC death occurred in the inner most rows 
of OHCs, with less damage in outer OHC rows that were farther away from the Tunnel of
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Corti (Figure 2-8). In addition, IHCs remained largely intact at P15 and even at 6 weeks 
of age (data not shown). This pattern of HC death is correlated with accumulation of 
daughter cells generated from p27-null PCs in the Tunnel of Corti area. Additionally, the 
pattern of HC death correlates to the distance between PCs and HCs; the shorter the 
distance, the more HC death occurred. We, therefore, propose that HC death was caused 
directly or indirectly by PC proliferation. The intact state of IHCs suggests that PCs 
prefer to proliferate and migrate laterally towards OHCs, but not medially towards IHCs. 
This is further supported by the cluster of BrdU+ PCs detected at P4 which appear to be 
migrating towards outer HCs.  
 
In addition, at P15 but not before, we found TUNEL positive (+), 
myosin-VIIa-negative cells in the apical surface of the organ of Corti. These TUNEL+ 
cells are either dying HCs that had lost myosin-VIIa expression and been ejected from the 
normal HC layer or perhaps PCs that migrated upward into the HC layer. The reason why 
cell death occurred two weeks after the initial proliferation is not clear, although similar 
phenomena have been reported previously in the retina.84, 85 Consistent with HC death 
observed after P10, our p27 CKO mice exhibited a significant increased auditory 
brainstem response threshold at 6 weeks of age. 
 
 
2.4 Summary and Discussion 
 
Using the Prox1CreER/+ mouse line, we have achieved in vivo proliferation of 
postnatal PCs by acutely deleting the cyclin-dependent kinase inhibitory protein, p27. 
Daughter cells of p27-null PCs undergo several rounds of division and migrate upward 
into the HC layer; however, they maintain SC fate and do not differentiate into HCs. The 
question of how to convert SCs to HCs is the topic of Chapter 4. Our work has 
accomplished both proliferation and migration of postnatal, mammalian SCs in vivo, two 
steps of the HC regeneration process that occurs in non-mammalian vertebrates. In 
addition, our model highlights SC heterogeneity as p27 is also deleted in postnatal DCs, 
yet we did not detect cell cycle reentry of DCs in our model.  
 
 
2.4.1 The p27 and cell cycle control in cochlear supporting cells   
 
The role of p27 during embryonic cochlear development is well established. It is 
first turned on in progenitors in the apical turn (E12.5) and last in the basal turns (E14.5) 
and drives the cell cycle exit of progenitors occurring in an apical-basal gradient.62 In 
p27-/- germ line knockout mice, the ectopic proliferation (or delayed cell cycle exit) of 
progenitor cells occurs and leads to supernumerary HCs that eventually die with aging 
partially because of overall defective cochlear development.64, 65 In postnatal cochleae of 
p27-/- germ line knockout mice, supernumerary HCs with expression of HC specific 
markers are quiescent and its postmitotic state is likely to be initiated and controlled by 
p19Ink4d (also called Cdkn2d), p21Cip1 (also referred as to Cdkn1a), and Rb.27,86-89 
Hereafter we will use p19 and p21 throughout the dissertation to define p19Ink4d and 
p21Cip1. 
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However, cells surrounding supernumerary HCs are still proliferative at postnatal 
ages in these mice. Because markers are not available to distinguish SC progenitors and 
differentiating SCs, there are two possible scenarios: the first is that the proliferative cells 
are SC progenitors (even in postnatal ages) which never exit the cell cycle and keep 
proliferation without p27; the second is that the proliferative cells are differentiating SCs. 
To distinguish between these two scenarios and clarify the roles of p27 at different 
postnatal ages (then cells at diverse differentiated state), it was best to delete p27 at 
different time points and bypass all embryonic defective development before p27 
ablation.  
 
Recently, in vitro transfection of neonatal cochleae with vectors expressing p27 
shRNA shows the importance of p27 in the SCs distributed in the LER region.90 
However, SCs (PCs and DCs) inside the organ of Corti which are cell types we focused 
on in current study are difficult to transfect. Therefore, we took the advantages of the 
conditional genetic mouse models in which we not only could target PCs and DCs but 
also at different ages. When p27 was specifically deleted at P0/P1, to our surprise, only 
p27-null PCs could proliferate which was different from presence of proliferative PCs 
and DCs in p27-/- germ line knockout mice.65 It might support that the SCs in p27-/- germ 
line knockout mice are more likely to be progenitor cell state and highlight the intrinsic, 
different differentiated states between neonatal SCs without p27 in our p27 conditional 
model and those without p27 from the beginning of their birth in p27-/- germ line 
knockout mice.65 
 
 
2.4.2 Comparison with avian HC regeneration 
 
After HC damage in the avian basilar papilla, SCs proliferate and migrate 
upwards into the HC layer.4 Daughter cells that differentiate into HCs remain in the HC 
layer, whereas daughter cells that maintain SC fate migrate again, downward to the SC 
layer.81 In our current model, p27-null PCs behave similarly by proliferating and 
migrating into the HC nuclear layer or even to the surface of the auditory epithelium. The 
difference, however, is that these daughter cells still express SC markers (Prox1 and 
Sox2), thus do not differentiate into HCs. 
 
It is possible that endogenous HCs prevent p27-null PCs from differentiating into 
HCs in a similar fashion to what occurs during embryonic development, where 
developing HCs prevent neighboring cells from also committing to HC fate by lateral 
inhibition.14, 24 Similarly, in the avian basilar papilla, HC regeneration does not occur 
unless HC damage happens first.4 Unfortunately, there are no effective means of 
damaging HCs in neonatal mice in vivo. Drugs-induced HC damage, using 
aminoglycoside antibiotics or platinum-based chemotherapy agents, are effective in adult 
mice or guinea pigs,51 but in neonates, result in death of the animal before HC death (our 
unpublished observation). Noise damage is also not an option as hearing is not fully 
mature until ~P21.63 
 
Another possible explanation for the lack of newly formed HCs in our model is  
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that p27-null daughter cells still express Sox2 and Prox1. It has recently been shown that 
both of these proteins suppress the activity of Atoh1,48 a transcription factor that is both 
necessary and sufficient for HC differentiation.38 Additionally, a recent report indicates 
that the cell fate of neonatal PCs is maintained by two pathways, the Notch pathway and 
the FGF pathway, during which hey2 is shown to be a key effector.91 Given such strong 
control of PC fate, it is likely that the expression of other differentiation proteins (i.e. 
Atoh1 to be discussed in Chapter 5) needs to be manipulated in order for p27-null PCs to 
differentiate into HCs. 
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CHAPTER 3.    SOX2 IS REQUIRED TO MAINTAIN QUIESCENCE OF INNER 
PILLAR CELLS 
 
 
3.1 Introduction 
 
In Chapter 2, we showed that acute ablation of cell cycle inhibitor p27 leads to 
proliferation of PCs. However, these p27-null PCs maintain the postnatal SC marker 
Sox2 and Prox1, suggesting that the SC cell fate is maintained. Because Sox2 is 
suggested to inhibit activities of Atoh1 during the embryonic cochlear development,48 we 
propose that Sox2 is required in maintaining the SC fate at postnatal ages and that the 
deletion of Sox2 will lead to the conversion of SCs into HCs. 
 
Sox2 germ line knockout mice are lethal at very early embryonic ages.92 In 
addition, two Sox2 hypomorphic mouse lines, Sox2Ysb/Ysb and Sox2Lcc/Lcc, have severely 
defective cochlear development 46. To bypass this limitation, we analyzed the Sox2 loxp/loxp 
mouse line that has been described previously.93 To specifically delete Sox2 at different 
postnatal ages, we characterized the tamoxifen inducible iCre (improved Cre) activity of 
Fgfr3iCreER+mice in cochlear cells.74 The majority of the iCre activity is limited to PCs 
and DCs when tamoxifen is given at postnatal ages. 
 
Contrary to our prediction, we did not observe a cell fate switch of Sox2-null PCs 
(can be subdivided into inner pillar cells and outer pillar cells) or DCs. In contrast, we 
found that Sox2-null inner pillar cells (IPCs) down-regulated p27, proliferated, while 
outer pillar cells (OPCs) and DCs were still quiescent and maintained normal expression 
of p27.  
 
 
3.2 Materials and Methods 
 
 
3.2.1 Mouse strains  
 
 Sox2 loxp/loxp mouse line was generated in Dr. Okuda Akihiko laboratory in 
Saitama Medical University (Japan). Fgfr3iCreER+mouse line was generated in Dr. 
William Richardson laboratory at the University College London (UK). CAG-EGFP+ 
mice were kindly provided by Dr. Jeffrey Robbins from the Cincinnati Children's 
Hospital Medical Center, Hes5LacZ/+ mice were kindly provided by Dr. Ryoichiro 
Kageyama from Kyoto University. Rosa26-CAG-Tdtomatoloxp/+, Notch1loxp/loxp and 
Rosa26-EYFPloxp/+ mice were purchased from Jackson laboratory (USA).  
 
 To characterize iCre activity, Fgfr3iCreER+; Rosa26-EYFPloxp/+ mice were treated 
with tamoxifen at P0 and P1, and analyzed at P6; Fgfr3iCreER+; CAG-EGFP+ mice 
were treated with tamoxifen at P6 and P7, and analyzed at P12; Fgfr3iCreER+; 
Rosa26-CAG-Tdtomatoloxp/+ mice that were treated with tamoxifen at P30 and analyzed at 
P40. Sox2 loxp/loxp mice were bred with Fgfr3iCreER+ mice to get Fgfr3iCreER+; Sox2 loxp/+. 
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Fgfr3iCreER+; Sox2 loxp/+ mice were interbred to get Fgfr3iCreER+; Sox2 loxp/loxp mice as the 
experimental group, while Fgfr3iCreER+; Sox2 +/+mice in the same littermate were used as 
the control group.  
 
 
3.2.2 Tissue preparation, immunofluorescence and analysis  
 
 Detailed protocols have been described in Chapter 2. The following primary 
antibodies were used: anti-Myosin-VI (rabbit, 1:200, 25-6791, Proteus Bioscience, 
Ramona, CA), anti-Myosin-VIIa (rabbit, 1:200, 25-6790, Proteus Bioscience), anti-Prox1 
(rabbit, 1:500, AB5475, Millipore, Billerica, MA), anti-Calbindin ( rabbit,1:500, 
AB1778, Millipore), anti-p75NGFR (rabbit, 1:1000, AB1554, Millipore), anti-GFP 
(chicken, 1:1000, ab13970, Abcam, Cambridge, UK), anti-p27 (mouse, 1:500, 610242, 
BD Transduction Laboratories, Franklin Lakes, NJ), anti-Sox2 (goat, 1:1000, sc-17320, 
Santa Cruz Biotechnology, Santa Cruz, CA), and Alexa Fluor 488-conjugated anti-pH3 
(rabbit, 1:20, 9708, Cell Signaling, Danvers, MA). The following secondary antibodies 
were used: donkey anti-rabbit Alexa Fluor 647 (1:1000, A31573, Invitrogen, Carlsbad, 
CA), donkey anti-chicken DyLt 488 (1:200, 703-486-155, Jackson ImmunoResearch, 
West Grove, PA), donkey anti-goat Alexa Fluor 568 (1:1000, A11057, Invitrogen), goat 
anti-rabbit Alexa Fluor 647 (1:1000, A21245, Invitrogen), goat anti-rabbit Alexa Fluor 
568 (1:1000, A11036, Invitrogen), and goat anti-chicken Alexa Fluor 488 (1:1000, 
A11039, Invitrogen).  
 
 Note that for p27 whole mount staining; we performed an antigen retrieval 
process (H-3300, Vector Laboratories, Burlingame, CA), followed by the Tyramide 
Signal Amplification Kit (T20912, Invitrogen) protocol recommended by Invitrogen. For 
cell death measurements, TUNEL staining was performed according to the protocol 
provided with the In Situ Cell Death Detection Kit, Fluorescein/TMR Red 
(11684795910/12156792910, Roche Applied Science, Indianapolis, IN). 
 
 
3.2.3 Luciferase assays and cell lines 
 
Plasmids for the p27 promoter driving the luciferase and the empty luciferase 
control were obtained from Dr. Toshiyuki Sakai, Kyoto Prefectural University of 
Medicine, Kyoto, Japan. LacZ, E2F1, and Sox2 expression vectors were obtained from 
Addgene (Cambridge, MA, plasmid 18816, 10736 and 13459). Luciferase and 
beta-galactosidase activity were assayed using the Applied Biosystems Dual-Light kit 
(Carlsbad, CA) and quantitated on a Promega (Madison, WI) Glomax Multi plate reader. 
Plasmids were co-transfected into approximately 10,000 MEF/HELA/HEK cells utilizing 
Lipofectamine LTX (Invitrogen, Carlsbad, CA), following the manufactures protocol at a 
7:1 ratio of LTX to DNA. HEK and immortalized MEF cells were obtained from Dr. 
Kundu (St. Jude Children’s Research Hospital). HELA cells were obtained from ATCC 
(Manassas, VA).  
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3.2.4 Chromatin immunoprecipitation (ChIP) assay 
 
ChIP was performed utilizing the Simple ChIP Magnetic kit (9003, Cell 
Signaling, Boston, MA). DNA was immunoprecipitated utilizing the ChIP formulated 
Sox2 antibody (5024, Cell Signaling, Boston, MA), or the H3 antibody (5275, positive 
control), liberated, purified and probed utilizing primers specific for either the putative 
Sox2 binding site (Forward: 5’-CAAGGCCTGCTTAGGATACT-3’, Reverse: 
5’-GGGGTTTTATTTATGACCTC-3’) or RPL30 (Cell Signaling). 
 
 
3.2.5 Auditory brainstem response and statistical analyses 
 
Detailed information was described in Chapter 2. 
 
 
3.3 Results 
 
 
3.3.1 Neonatal inner pillar cells proliferate after acute deletion of Sox2  
 
 In the neonatal and adult mouse cochlea, Sox2 is highly expressed in SCs inside 
the organ of Corti, in cells of the greater epithelium ridge (GER), and in Hensen cells 
lateral to the organ of Corti. Inside the organ of Corti, there are two types of pillar cells 
(PCs), inner pillar cells (IPCs) and outer pillar cells (OPCs), and Deiters’ cells (DCs), all 
of which reside underneath the auditory HCs (Figure 3-1A). To determine the roles of 
Sox2 in IPCs, OPCs and DCs, we first characterized the Fgfr3iCreER+ transgenic mouse 
line by crossing it with the Rosa26-EYFPloxp/+ reporter mouse line. Fgfr3iCreER+; 
Rosa26-EYFPloxp/+ mice were given tamoxifen at P0 and P1 and analyzed at P6. There 
were many EYFP+ cells throughout the entire cochlea (Figure 3-1B-D’). Inside the organ 
of Corti, the majority of EYFP+ cells were Prox1+ IPCs, OPCs and DCs, and a very 
small fraction were OHCs, Hensen and Claudius cells (Figure 3-1E). Note that EYFP+ 
IHCs were never found. When EYFP+ DCs, PCs or OHCs were normalized to the total 
number of DCs, PCs or OHCs in the same confocal scanning region (n=3), approximately 
70% of PCs and DCs were EYFP+, and only 1% - 2% of OHCs were EYFP+ (Figure 
3-1F). In addition, in each ~160 µm cochlear duct, a few (2 ± 2, n=3) EYFP+ Hensen or 
Claudius cells were frequently observed in the lesser epithelium ridge (LER), which are 
not the cell types of our focus here. Although iCre activity of Fgfr3iCreER+ mice is not 
100% specific to SCs, it is suitable for our study because Sox2 is undetectable in all 
postnatal HCs.  
 
Next, we crossed Fgfr3iCreER+ with Sox2loxp/loxp mice and gave Fgfr3iCreER+; Sox2 
loxp/loxp pups tamoxifen at P0 and P1, EdU at P2 and analyzed their cochleae 6 hours later. 
While HCs remained intact, Sox2 was deleted in IPCs, OPCs and DCs across the entire 
cochlea and many EdU+ cells were identified. We quantified EdU+ cells along the entire 
cochlea (5544 µm ± 88 µm, n=3). In each sample, there were86 ± 11 (n=3) EdU+ cells. 
Among the total 259 EdU+ cells in three samples (all of which were Sox2-negative), 
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81% (210/259) were in the apical turn, 19% (49/259) in the middle turn, while no EdU+ 
cells were found in the basal turn. Intriguingly, all of the 259 EdU+ cells were IPCs 
which were defined by their unique oblong shape and location (Figure 3-2A-B’’). This 
implies that ablation of Sox2 at P0 and P1 leads to S phase reentry only in IPCs. In 
control mice, Sox2 was expressed in all PCs and DCs, and consequently there were no 
EdU+ SCs observed (Figure 3-2C). As an internal positive control, EdU+ mesenchymal 
cells underneath SCs were found in control mice (Figure 3-2C’). 
 
When Fgfr3iCreER+; Sox2loxp/loxp mice were given tamoxifen at P0 and P1, EdU at 
P4 and analyzed 6 hours after EdU injection, we found EdU+ IPCs but no other SC 
subtypes across the whole turns were labeled by EdU. Strikingly, when triple staining of 
p27, Sox2 and EdU was performed, we observed EdU+/Sox2-negative/ p27-negative 
IPCs (8 ± 3, averaged in 9 randomly picked 160 µm length of cochlea in three samples) 
across the entire cochlea at P4 (Figure 3-2D-D’’’). Faint but detectable p27 was present 
in a few Sox2-negative/ EdU-negative IPCs (arrow heads in Figure 3-2D-D’’’). It 
highlights the delay between Sox2 ablation and complete degradation of the remaining 
p27 protein; however, all EdU+ IPCs were Sox2-negative/p27-negative. We did not 
analyze older ages because we were no longer confident in our ability to distinguish 
OPCs from new daughter cells produced by the proliferating Sox2-negative IPCs. 
Interestingly, expression of p27 was still maintained in all Sox2-negative OPCs and DCs 
(Figure 3-2D-D’’’), which might account for why only Sox2-negative IPCs could 
proliferate. To further determine whether EdU+ IPCs could also enter the mitotic (M) 
phase, we performed double staining of EdU and phospho-histone 3 (pH3, mitotic 
marker) and a few EdU+/ pH3+ IPCs were observed (Figure 3-2E). This suggests that 
Sox2-negative IPCs are able to finish S phase and enter M phase within 6 hours. Taken 
together, these findings demonstrate that Sox2 is required to maintain the quiescence of 
IPCs at neonatal ages.  
 
Sox2 is believed to be an upstream regulator of Prox1 at embryonic ages. We 
determined the Prox1 expression pattern in Sox2-negative SCs, and found that Prox1 was 
maintained in all Sox2-negative IPCs, OPCs and DCs. This suggests that Sox2 is 
dispensable in maintaining Prox1 expression by P4 (Figure 3-2F-G’’). We did not 
analyze samples at older ages due to the fact that Prox1 expression is down-regulated 
with age under control conditions. Finally, in all cochlear samples analyzed at both P2 
and P4, we never observed EdU+/Myosin-VI+ cells or extra HCs. It not only supports 
our assumption that deletion of Sox2 in 1% - 2% of Cre+ OHCs does not result in a 
detectable phenotype, but also suggests that no new HCs were generated upon Sox2 
deletion in SCs. 
 
 
3.3.2 Juvenile inner pillar cells proliferate after acute deletion of Sox2  
 
 Because cochlear development advances significantly during the first week after 
birth, we deleted Sox2 in juvenile SCs (P6 and P7) and tested whether they still need 
Sox2 to remain quiescent. To measure the amount of iCre activity upon tamoxifen 
induction at P6 and P7, we crossed CAG-EGFP+ with Fgfr3iCreER+ mice. Fgfr3iCreER+;
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CAG-EGFP+ mice were given tamoxifen at P6 and P7 and analyzed at P15. We switched 
to CAG-EGFP+ reporter mice because we found that the Rosa26 promoter activity 
becomes weaker with age in the cochlea. Again, the majority of EGFP+ cells in the organ 
of Corti were IPCs, OPCs and DCs, while a few OHCs, Henson and Claudius cells were 
also EGFP+. Approximately 93% of PCs and DCs were EGFP+ (Figure 3-3A-B). We 
then used Fgfr3iCreER+; Sox2loxp/loxp mice as the experimental group and Fgfr3iCreER+; 
Sox2+/+ mice as the control group, both of which received the same treatments. 
 
 Fgfr3iCreER+; Sox2loxp/loxp mice were treated with tamoxifen at P6 and P7, EdU at 
P8 and analyzed 6 hours after EdU injection at P8 (Figure 3-3C-C’’). In each cochlea, 
there were 45 ± 12 (n=3) EdU+ cells. In three cochleae (5733 µm ± 75 µm), a total of 
137 EdU+ cells were found throughout the entire cochlea and all were Sox2-negative. Of 
these, 34.3% (47/137) were distributed in the apical turn, 37.1% (51/137) in the middle 
turn and 28.5% (39/137) in the basal turn. All EdU+ cells were IPCs, again confirming 
that Sox2-negative IPCs reentered S phase after acute Sox2 deletion (Figure 3-3C’’). We 
were still confident in our ability to define EdU+ cells as IPCs because of their location 
and the unique structure of organ of Corti at P8. In addition, a few EdU+/ 
pH3+/Sox2-neative IPCs (8 ± 2, n=3) were observed (Figure 3-3D-D’’’). Furthermore, 
triple staining of EdU, Sox2 and p27 showed that p27 became undetectable in all EdU+/ 
Sox2-negative IPCs. Again, while the vast majority of Sox2-negative IPCs were also 
p27-negative (arrows in Figure 3-3E-E’’’), some Sox2-negative IPCs still had a 
detectable level of p27 (arrow heads in Figure 3-3E-E’’’). This observation is either due 
to a delay between Sox2 ablation and elimination of p27, or suggests the possibility that a 
small minority of IPCs do not need Sox2 to maintain p27 expression at P6 and P7. Note 
that both Sox2+ and Sox2-negative OPCs and DCs continued to express p27, consistent 
with the absence of EdU in these cell types (Figure 3-3E-E’’’). It is worthy to highlight 
that the total number of EdU+ IPCs here (137 in three cochleae) was much less than the 
total number of EdU+ IPCs when Sox2 was deleted at P0 and P1 (259 in three cochleae). 
Because more SCs are Cre+ when tamoxifen was given at P6 and P7 (93%) than at P0 
and P1 (70%), it suggests that proliferative capacity of IPCs likely declines with 
maturation. In addition, no EdU+/Calbindin (another HC marker)+ cells or extra HCs 
were found, which again illustrates that deletion of Sox2 in a few Cre+ OHCs does not 
cause a phenotype and that Sox2-negative SCs did not switch into HCs. Finally, in the 
control mice, we did not find any EdU+ or pH3+ cells inside the organ of Corti (data not 
shown). 
 
 
3.3.3 Sox2 deletion in adult inner pillar cells leads to limited proliferation 
 
 Because Sox2 expression is maintained in adult SCs,50 we acutely deleted Sox2 in 
adult SCs at P30. To characterize Cre activity at this age, Fgfr3iCreER+; 
Rosa26-CAG-Tdtomatoloxp/+ mice were given tamoxifen once at P30 and analyzed at P40 
(Figure 3-4A). In contrast to our tamoxifen induction at neonatal and juvenile ages, all 
Tdtomato+ cells were SCs, which highlights the specificity of Cre activity in the 
Fgfr3iCreER+ mice at adult ages. Approximately 95% of all DC and PC were Tdtomato+, 
demonstrating the high efficiency of one tamoxifen injection. Fgfr3iCreER+; Sox2loxp/loxp 
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mice were subjected to tamoxifen at P30, EdU at P32 and were analyzed 6 hours after 
EdU injection. Only 5 ± 3 (n=3) EdU+/Sox2-negative IPCs were found across the entire 
cochlea (Figure 3-4B-B’), though almost all SCs have lost Sox2 expression (Figure 
3-4C-C’’’). Adult IPCs have lost their oblong shape, which forced us to define cells as 
IPCs based on their location. The limited number of EdU+ cells prompted us to speculate 
that adult Sox2-negative SCs might require a longer time to reenter S phase. Because 
adult mice can tolerate multiple EdU injections, Fgfr3iCreER+; Sox2loxp/loxp mice were given 
tamoxifen at P30, followed by EdU injection at P34, P36, P38 and P40 and analyzed 6 
hours after their last EdU injection. In each sample Sox2 staining was performed to 
confirm that deletion of Sox2 did occur (data not shown). However, only 1 ± 1 (n=4) 
EdU+/Sox2-negative IPC was found across the entire cochlea (Figure 3-4D-D’). 
EdU+/Sox2-negative OPCs and DCs were never observed. As expected, in Fgfr3iCreER+; 
Sox2 +/+ control mice, no EdU+ cells were observed inside the organ of Corti (data not 
shown). Taken together, these data suggest that adult IPCs show a very limited capacity 
to proliferate in the absence of Sox2.  
 
 All data described above suggest that Sox2 is a positive upstream regulator of 
p27. In support with this conclusion, as described in Chapter 2, deletion of p27 in 
neonatal PCs caused proliferation of both IPCs and OPCs. Because p27Kip1 expression is 
maintained in adult SCs,65,94 we then determined whether acute ablation of p27 in adult 
(P30) PCs would also lead to a similar phenotype as Sox2 ablation in adult SCs. Because 
Prox1 becomes undetectable at adult ages,83 Prox1CreER/+ mice cannot be used. Instead we 
analyzed Fgfr3iCreER+; p27loxp/loxp mice that were given tamoxifen once at P30, and given 
EdU once at P32, P33, P34 and analyzed at P35 (Figure 3-5A-A’’’). We observed a very 
limited number of EdU+ cells (4 ± 2, n=3) (Figure 3-5B-C’’’). The lack of SC specific 
markers does not allow us to further characterize their identities. In contrast, as internal 
controls, 116 ± 20 (n=3) EdU+ cells could be found in the lesser epithelium ridge (LER) 
area in the whole cochlea (arrows in Figure 3-5B). 
 
 
3.3.4 Functional consequences due to inducible loss of Sox2 in the mouse cochlea 
 
 Previous studies have shown that uncontrolled proliferation of cochlea SCs may 
result in hair cell death,64,65,87-89 which prompted us to examine the effect of inducible 
loss of Sox2 on the long term health of the HCs, and the ability of the mouse to hear. 
 
 Fgfr3iCreER+; Sox2loxp/loxp mice were given tamoxifen at P0 and P1, EdU once at 
P15 and analyzed at P16 to characterize the morphology of the organ of Corti and to ask 
if Sox2-negative cells continue to proliferate until P15 (Figure 3-6A-B’). As expected, we 
found significant HC loss. The majority of the lost HCs were OHCs, while a small 
fraction of them were IHCs. More HCs were lost in apical turns than middle or basal 
turns. Across the entire cochlea, 5 ± 2 (n=3) EdU+ cells were found at P16, suggesting 
that some Sox2-negative IPCs keep proliferating between P2 and P16 (Figure 3-6C-D). 
Inside the tunnel of Corti, there were supernumerary SCs (almost all were Sox2-negative) 
which were likely daughter cells produced from Sox2-negative IPCs (Figure 3-6E). 
Presence of TUNEL+ cells at P16 suggests that cell death is occurring in the area (Figure 
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3-6F-F’). Absence of TUNEL+/EdU+ cells indicates that the EdU+ cells are proliferating 
cells, but not dying cells (Figure 3-6G). 
 
 
3.3.5 Overexpression of Sox2 results in activation of the p27 promoter in vitro 
 
 To understand if Sox2 can modulate the p27 promoter, we used a construct in 
which luciferase is driven by the p27 promoter (Figure 3-7A).95 We then transfected this 
construct, along with an internal control of LacZ and either E2F1, Sox2 or an empty 
vector into different cell lines. Because Sox2 binding has been demonstrated to be 
dependent on its distinct binding partners in different cell types, we chose to examine the 
effects of Sox2 overexpression in three distinct cell types: Mouse Embryonic Fibroblasts 
(MEF), HELA, Human Embryonic Kidney Cells (HEK). When transfections were 
performed on all three cell types, we found that overexpression of E2F1, a known 
regulator of the p27 promoter, resulted in up-regulation of luciferase as measured by 
luciferase activity. Overexpression of Sox2 led to a significant up-regulation of luciferase 
in both MEF and HELA cells, but had no effect in HEK cells (Figure 3-7B-D). All 
luciferase luminosity was normalized to beta-galactosidase luminosity in order to account 
for any changes due to cell viability and transfection efficiency. 
 
 
3.3.6 Endogenous levels of Sox2 bind near the p27 locus 
 
 Recently, next generation sequencing was used to sequence all potential binding 
sites of Sox2 in the entire genome of mouse embryonic stem cells via ChIP-Seq.96,97 Both 
reports identified a putative Sox2 binding site in a region downstream of the p27 locus 
(illustrated in Figure 3-7E, chromosome 6 base pairs 134880326-134880400), as well as 
a potential consensus sequence for Sox2 binding 5’-CATTGTT-3’.96 To understand if 
this consensus sequence is represented in the p27 promoter in our construct, we 
performed a simple search of the p27 locus (plus 2kb upstream and 4kb downstream) for 
any sequence with at least 70% homology to the published consensus sequence. We 
identified multiple Sox2 consensus sites in both the 5’ promoter region and the 
downstream region near the Sox2 binding site identified in the ChIP-seq studies.96 The 
two most conserved sequences in both the 5’ promoter region and the downstream region 
are shown in Figure 3-7E, demonstrating that the putative Sox2 recognition sequence 
exists in both the promoter region and the downstream Sox2 binding site.  
 
 However, the very limited amount of IPCs in the cochlea prevented us from 
demonstrating that this interaction exists in IPCs. To understand if it is possible for Sox2 
to regulate p27 we performed ChIP in MEF cells, a cell type which responded strongly to 
Sox2 overexpression in the luciferase reporter assays and obtained a positive band when 
primers specific for the putative Sox2 binding site were used (Figure 3-7F-G). Taken 
together these data suggest that not only can overexpression of Sox2 activate the p27 
promoter, but endogenous Sox2 can directly bind to its regulatory regions and control this 
interaction. 
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3.4 Summary and Discussion 
 
 Here we demonstrate that Sox2 is required to maintain the quiescent state of 
neonatal and juvenile IPCs. Deletion of Sox2 led to repression of p27 and subsequent 
proliferation of IPCs. Deleting p27 also resulted in proliferation of IPCs, as well as 
OPCs; however these cells continued to express Sox2, suggesting that Sox2 is upstream 
of p27. In addition, luciferase reporter assays and Sox2-ChIP demonstrated that Sox2 can 
act as an activator of the p27 promoter, and can interact with regulatory regions of the 
p27. Together these data demonstrate that regulation of p27 by Sox2 is an important 
pathway involved in maintaining quiescence of IPCs. Furthermore these data clearly 
demonstrate the inherent heterogeneity that exists within the SC population of the organ 
of Corti. Only IPCs are sensitive to the Sox2-p27 repression of proliferation. Whereas 
OPCs need p27 but no longer Sox2, and DCs require neither proteins for cell cycle 
reentry. Finally this signaling cascade seems to be age-dependent because adult IPCs 
showed very limited response to the absence of either Sox2 or p27. 
 
 
3.4.1 A novel role for Sox2 in postnatal cochlear supporting cells 
 
 In many mouse embryonic tissues such as the retina, Sox2 is highly expressed in 
proliferating progenitors and its loss leads to defective proliferation.52 This suggests a 
general role for Sox2 to promote proliferation in embryonic tissue cells, which might 
explain the severe defective inner ear development in the two Sox2 hypomorphic mouse 
models.46 However, by deleting Sox2 specifically in postnatal cochlear SCs, we found the 
opposite and demonstrated that Sox2 is required to keep neonatal and juvenile IPCs 
quiescent in part by maintaining expression of p27. Interestingly, Sox2 is dispensable for 
expression of p27 in OPCs and DCs. Also, it is unlikely that Sox2 deletion in postmitotic 
SCs would dedifferentiate them into their original progenitor state because prosensory 
progenitors are also Sox2+. This novel role for Sox2 in regulating its target p27 may be 
important for other tissues and cell types. 
 
 
3.4.2 Heterogeneous effects of Sox2 ablation in different supporting cells 
 
 Sox2 is robustly expressed in SCs, but loss of Sox2 results in drastically different 
phenotypes in IPCs versus OPCs or DCs. To explain the different phenotypes caused by 
Sox2 deletion, we need to consider our luciferase reporter experiments, which showed 
that different cell types respond differently to Sox2 overexpression. We saw a lack of 
Sox2-p27 regulation in HEK cells, implying that this cell type does not express the 
appropriate co-factors for Sox2 to regulate p27 promoter, whereas MEF and HELA cells 
are able to maintain this regulation. This is also in line with the current notion that Sox2 
must cooperate with diverse binding partners in different cell types to efficiently drive 
expression of target genes.45 It is possible that like HEK cells, OPCs and DCs lack the 
Sox2 binding partners needed for interaction with p27, whereas IPC, MEF and HELA 
cells retain them, allowing for Sox2-dependent p27 expression. Alternatively, it is also 
possible that other Sox family members such as Sox949 and Sox1098 may compensate for 
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Sox2 ablation in these cell types. Nonetheless, it will be informative in future studies to 
identify the potential binding partner (s) for Sox2 in IPCs. Finally, adult Sox2-negative 
IPCs showed limited proliferation which is in line with the general proposal that fully 
matured cells have declined proliferative capacity. This may also reflect a time-dependent 
shift away from the Sox2-p27 pathway for regulation, potentially through a shift in Sox2 
binding partners available within IPCs. 
 
 
3.4.3 Heterogeneous signals of cell cycle regulation in different supporting cells  
 
 Interestingly, different proliferative phenotypes were observed when different cell 
cycle inhibitors were acutely deleted in neonatal SCs. For instance when Rb was deleted 
in neonatal DCs and PCs, both cell types proliferated.73 As described in Chapter 2, 
deletion of p27 in neonatal DCs and PCs resulted in proliferation of only PCs. Deletion of 
Sox2 in neonatal and juvenile DCs and PCs caused proliferation in only IPCs, but not 
OPCs or DCs. This partial overlap of phenotypes demonstrates the importance and 
potential hierarchy of the cell cycle control pathway in which Rb is the key downstream 
player. 
 
 This finding is somewhat surprising in that p27 is not necessary to keep DCs 
quiescent because p27 is the only cell cycle inhibitor reported in postnatal DCs.94 
However it is possible that DCs lack key positive cell cycle regulators, and thus do not 
need p27 to maintain quiescence. Consistently, cyclin D1 controls the proliferative 
capacity of HCs in p19-/-; p21-/- double knockout mice,94 and only those HCs with cyclin 
D1 expression proliferate. Because postnatal DCs have undetectable or very low levels of 
cyclin D1,94 it might account for why p27-negative DCs do not proliferate. Consistently, 
neonatal but not adult PCs have high levels of cyclin D1,94 and p27-negative neonatal but 
not adult PCs do proliferate. 
 
 
3.4.4 Transient modulation of Sox2 and p27 for mammalian hair cell regeneration 
 
 When HC damage occurs in non-mammalian vertebrates such as birds, fish and 
amphibians, the surrounding SCs proliferate and transdifferentiate into HCs to rescue 
hearing capacity. When the process of HC regeneration is completed, SCs return to a 
state of quiescence again. Decreased proliferation of SCs in Phoenix mutant Zebrafish 
leads to defective HC regeneration,99 which further highlights the importance of SC 
proliferation in HC regeneration. However, mammals SCs are strictly kept quiescent even 
after HC damage occurs. This might partially account for the inability of mammals to 
regenerate HCs. Therefore, to restore mammals with the competence to regenerate HCs 
after damage, driving SCs to proliferate may be a necessary step. We have shown that the 
Sox2-p27 signaling pathway in IPCs and the signaling pathway involving p27 and 
unknown upstream regulator in OPCs are required to keep these cells quiescent. Given 
the high levels of both Sox2 and p27 expression in SCs, the development of transient 
inhibitors of either Sox2 or p27 would allow SCs to proliferate and, in combination with 
local delivery, such treatment could have specific effects on inner ear cochlear SCs. 
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3.5 Future Work 
 
 Our data clearly showed that Sox2-negative IPCs but not OPCs can proliferate. 
One interesting question is what are the factors that prevent Sox2-negative OPCs from 
proliferating. Answering this question definitively will further help to elucidate the 
molecular mechanisms keeping SCs quiescent at postnatal ages and provide more 
potential strategies to stimulate SC proliferation to promote HC regeneration. While there 
are many possible explanations accounting for this, one simple scenario is that some 
unknown factors in OPCs can compensate for the loss of Sox2. Two criteria might be 
used to choose such candidate factors: 1) they should be enriched, if not exclusively, in 
OPCs but not in IPCs; 2) as suggested by the literature, they should be able to regulate 
the proliferative state of SCs. 
 
 Based on the above criteria, we propose that Hes5, a Notch1 signaling target gene, 
could compensate for the loss of Sox2 in neonatal and juvenile OPCs. This is supported 
by the two following preliminary data: First, in Hes5LacZ/+ knock-in mice in which the 
Hes5 open reading frame is replaced by LacZ, causing that Hes5-LacZ allele is a null 
mutation.100 LacZ is expressed in OPCs but not in IPCs, while LacZ is also expressed in 
DCs (Figure 3-8A-B). Second, besides regulating the prosensory region formation and 
further controlling cell fate specification, Notch1 signaling (or its target genes) is also 
involved in cell cycle regulation of SCs around perinatal stages, as supported by the fact 
that excessive proliferative of SCs are observed in the Jagged2/Delta1 double KO mice 
where Notch1 signaling is defective.14   
 
 To test this idea, we planned to analyze Fgfr3iCreER+; Sox2loxp/loxp; Hes5LacZ/LacZ 
mice that will be injected with tamoxifen at P0 and P1, and analyzed at different time 
points. If OPCs without Sox2 and Hes5 proliferate, it will strongly suggest that Hes5 
compensates for the Sox2 deletion in the Fgfr3iCreER+; Sox2loxp/loxp mouse model. 
However, one disadvantage of the Fgfr3iCreER+; Sox2loxp/loxp; Hes5LacZ/LacZ model is that 
homozygous germline loss of Hes5, to some extent, causes defective embryonic cochlear 
development.28 Alternatively, to similarly block Hes5 function or Notch1 signaling 
activities, we will use Fgfr3iCreER+; Sox2loxp/loxp; Notch1 loxp/loxp mice. Fgfr3iCreER+; 
Sox2loxp/loxp; Notch1 loxp/loxp mice will be injected with tamoxifen at P0 and P1, and 
analyzed at different ages. Because Notch1 is the only Notch receptor expressed in mouse 
cochlea,18 deletion of Notch1 should block Notch activities. To guarantee that other 
Notch receptors will not compensate the loss of Notch1, we have analyzed CAGCreER+; 
Notch1loxp/loxp; Hes5LacZ/+ mice (experimental group) where all cells including SCs are 
targeted and Notch1loxp/loxp; Hes5LacZ/+ mice (control group). Both groups were injected 
with tamoxifen at P0 and P1, and analyzed at P7 (Figure 3-8B-C). Hes5 was used as a 
reporter gene for Notch activities. We found that the number of Hes5+cells were 
significantly decreased in CAGCreER+; Notch1loxp/loxp; Hes5LacZ/+ mice, relative to 
Notch1loxp/loxp; Hes5LacZ/+ mice (Figure 3-8B-C). Notch1loxp/loxp; Hes5LacZ/+ mice (Figure 
3-8B-C). It further confirmed that loss of Notch1 will cause defective Notch activities in 
SCs.  
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CHAPTER 4.    OVERACTIVATION OF NOTCH 1 SIGNALING GENERATES 
NEW HAIR CELLS AT EARLY EMBRYONIC AGES 
 
 
4.1 Introduction 
 
 The otocyst derived cochlear cells roughly can be divided into three groups, 1) 
sensory HCs and SCs inside the organ of Corti; 2) non-sensory cells in LER or GER 
regions; 3) the cochlear spiral ganglion neurons (SGNs). There is a belief that mouse 
HCs, SCs and SGNs originate from the same early common neural-sensory progenitor 
cells, mainly based on studies of the chick inner ear development.101 Recently, such a 
model has been further supported but it has not been definitively proven by mouse inner 
ear development studies.102,103 These neural-sensory progenitor cells further commit into 
two subgroups, prosensory progenitors that develop into HCs or SCs, and neural 
progenitor cells that differentiate into SGNs. 
 
 Morphogenesis of cochlear HCs is a complex but step-by-step process. Notch1 
signaling is able to specify progenitor cell populations among cochlear cells. Therefore, it 
is interesting to test whether overactivation of Notch1 signaling in cochlear non-sensory 
cells can convert them into progenitor cells which are further permissive to become HCs 
or SCs, by using genetic mutant mouse models.  
 
To induce ectopic Notch1 signaling independently of Notch1 receptor proteolysis, 
a genetic knock-in mouse model has been generated where the Notch1 intracellular 
domain (NICD) is driven by a ubiquitously active Rosa26 promoter.104 However, there is 
a “stop” sequence flanked by two loxP sequences in the same orientation, thus upon 
Cre-mediated deletion of the “stop” sequence, NICD transcription is induced. To induce 
ectopic NICD expression in non-sensory cells, we used a CAGCreER+ mouse line in which 
tamoxifen inducible Cre activity is ubiquitously expressed.  
 
 
4.2 Materials and Methods 
 
 
4.2.1 Mouse strains  
 
 Rosa26-NICDloxp/+, Notch1Cre (low) /+, Rosa26-EYFPloxp/+ and 
Rosa26-CAG-Tdtomatoloxp/+ were purchased from Jackson Laboratory (USA). The 
CAGCreER+ mouse line was obtained from Dr. Guillermo Oliver (St. Jude Children’s 
Research Hospital) with permission from Dr. Andrew McMahon (Harvard University). 
Mice were crossed at 5 pm and the next morning was designated as E0.5 when vaginal 
plugs were found. Pregnant female mice were given tamoxifen (intraperitoneal, 100 µg/g 
body weight) once when embryos were at ~E10.5, ~E13.105 All animal work conducted in 
this study was approved by the Institutional Animal Care and Use Committee at St. Jude 
Children's Research Hospital and performed according to NIH guidelines.  
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4.2.2 Histology and immunofluorescence 
 
 Detailed histological procedures have been described in Chapter 2. Cochlear 
samples of the inner ear were processed by our routine protocols described previously. 
All images were examined using a Zeiss LSM 700 confocal microscope. The following 
primary antibodies were used: anti-Myosin-VI (rabbit, 1:200, 25-6791, Proteus 
Bioscience, Ramona, CA), anti-Sox10 (goat, 1:250, sc-17342, Santa Cruz 
Biotechnology), anti-TUJ1 (mouse, 1:1,000, MMS-435P, Covance, Princeton, NJ), 
anti-GFP (chicken, 1:1000, ab13970, Abcam, Cambridge, UK), The following secondary 
antibodies were used: donkey anti-rabbit Alexa Fluor 647 (1:1000, A31573, Invitrogen), 
donkey anti-chicken DyLt 488 (1:200, 703-486-155, Jackson ImmunoResearch, West 
Grove, PA), donkey anti-goat Alexa Fluor 568 (1:1000, A11057, Invitrogen), goat 
anti-rabbit Alexa Fluor 568 (1:1000, A11036, Invitrogen), goat anti-mouse Alexa Fluor 
647 (1:1000, A21236, Invitrogen) and goat anti-chicken Alexa Fluor 488 (1:1000, 
A11039, Invitrogen).   
 
 
4.2.3 Cell counting  
 
 The entire cochlear was carefully divided into basal, middle and apical turns. 
Using the preliminary low magnification confocal image, the length of each turn was first 
measured by drawing a line in the middle of the outer hair cells (OHCs) and the inner 
hair cells (IHCs). By defining the basal hook part as 0% and the most apex portion as 
100%, the 25%, 50%, and 75% areas were used to represent basal, middle and apical 
turns, respectively. Confocal Z stack scanning was then performed at 1 µm intervals. 
 
 
4.2.4 Statistical analyses   
 
 All data were expressed as mean ± SEM. Cell counts were compared by a 
one-way ANOVA, followed by a Student’s t test with a Bonferroni correction. GraphPad 
Prism 5.0 was used for all statistical analyses. 
 
 
4.3 Results  
 
 
4.3.1 Constitutive overactivation of NICD in otocyst cells generates hair cells   
 
 CAGCreER+ mice were bred with Rosa26-NICDloxp/+ mice to get the CAGCreER+; 
Rosa26-NICDloxp/+ as experimental groups, and CAGCreER-; Rosa26-NICDloxp/+ as control 
groups. In this study, cochlear samples were treated with tamoxifen at different 
developmental stages. The earliest tamoxifen injection was at ~E10.5, because it was 
difficult to obtain live mutant embryos at perinatal ages when the pregnant mother was 
given tamoxifen at ~E9.5 or earlier. After Cre-mediated recombination, NICD and EGFP 
transcription are coupled to the same Rosa26 promoter. Thus, EGFP should faithfully 
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reflect NICD expression. Although the CAG promoter is ubiquitously active, with a 
single tamoxifen injection the mice can be considered mosaic, similar to chimeric mice in 
which wild-type and mutant cells (with ectopic NICD) are randomly mixed together. 
Because tamoxifen frequently caused dystocia, we analyzed embryos at ~E19 (equivalent 
to P0 in most cases). 
 
 Ectopic sensory areas containing Myosin-VI+/EGFP– HCs were also found in the 
cochlea (Figure 4-1). There are three regions with ectopic HCs. The first was the cochlear 
spiral ganglion (SGN) area (Figure 4-1G-G’’ and Figure 4-1K-L’). Among the EGFP+ 
patches (15 ± 5, n=4), approximately half contained variable numbers (7 ± 2) of new 
HCs. Interestingly, patches with new HCs were larger than those without new HCs. The 
second region was the endogenous organ of Corti. An expanded organ of Corti with 
supernumerary HCs was found in the basal or apical turn (n=4) (Figure 4-1H-H’’). The 
third region was lesser epithelium ridge (LER) where ectopic clustered HCs (6 ± 4, n=4) 
were observed (Figure 4-1J). In all three areas, cells (either EGFP+ or EGFP–) 
surrounding these new HCs expressed Sox10, a SC marker (Figure 4-2). Notably, the 
greater epithelial ridge (GER) areas (n=4), which contained many EGFP+ cells, had no 
Myosin-VI+ HCs (Figure 4-1H-I). It is consistent with another recent report where 
different chick inner ear cells respond differently to overactivation of Jagged1.106 No 
abnormal phenotype was found in control CAGCreER -; Rosa26-NICDloxp/+ embryos 
subjected to tamoxifen at ~E10.5 (n=3, data not shown).  
 
 
4.3.2 Cellular responsiveness to ectopic NICD declines during mouse cochlear 
development 
 
 Next, CAGCreER+; Rosa26-NICDloxp/+ embryos were treated with tamoxifen once 
at ~E13. Although numerous EGFP + cells were found in cochleae (n=4), no ectopic HCs 
were detected (Figure 4-3).  
 
 To confirm the age-declined response of cochlear cells to ectopic NICD 
expression, neonatal CAGCreER+; Rosa26-NICDloxp/+ mice were further treated with 
tamoxifen at P0 and P1, and analyzed at P10. However, the tracer EGFP became faint 
and difficult to visualize at P10, possibly because of decreased Rosa26 promoter activity 
and IRES-mediated EGFP translation. Similar difficulties have been encountered in older 
retina cells.107 Therefore, to better visualize cells with Cre-mediated recombination, we 
crossed CAGCreER+; Rosa26-NICDloxp/loxp with Rosa26-EYFPloxp/loxp to get CAGCreER+; 
Rosa26EYFP/NICD mice as the experimental group, and CAGCreER -; Rosa26EYFP/NICD 
littermates as controls. EYFP was used to visualize most of the cells with ectopic NICD. 
Note that, because EYFP and NICD were not strictly coupled to the same Rosa26 locus 
promoter, there were some EYFP+ cells that might not have ectopic NICD expression or 
some EYFP-negative cells that indeed expressed ectopic NICD. CAGCreER+; 
Rosa26EYFP/NICD mice were treated with tamoxifen at P0 and P1, and analyzed at P10. 
Similar to Figure 4-3, many EYFP+ cells were observed, but again no new HCs were 
identified (data not shown).  
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4.3.3 Almost all cochlear progenitors experiencing Notch1 signaling commit to 
supporting cell fate in normal development 
 
 Our data suggest that, although NICD overactivation can specify ectopic sensory 
patches or progenitors, cells with constitutive NICD exclusively develop into SCs. To 
further understand whether it is also true in normal cochlear development, we planned to 
perform genetic fate mapping analysis of the cochlear cells experiencing Notch1 
signaling.  
 
 We crossed the Notch1Cre (Low)/+ mouse line where Notch1 intracellular domain 
(NICD) was replaced by 6×Myc–tagged Cre recombinase with the nuclear localization 
signal (NLS), resulting in a null mutation of Notch1.108 Heterozygous mice are fertile and 
viable whereas homozygous mice die at ~E9.5, which is consistent with results of two 
Notch1 knockout mouse lines previously characterized.109,110 In Notch1Cre (Low)/+ mouse, 
binding of Notch ligands to the intact extracellular domain of the Notch1 receptor 
triggers proteolytic cleavage of the Notch1 receptor transmembrane domain, release of 
Cre from the plasma membrane, and subsequent translocation of Cre into nuclei. When 
Notch1Cre (Low)/+ mice are crossed with conditional Rosa26-CAG-Tdtomatoloxp/+ mice, 
cells with Notch1 activity and their descendants can be permanently traced with red 
fluorescent protein Tdtomato in Notch1Cre (Low)/+; Rosa26-CAG-Tdtomatoloxp/+ mice 
(Figure 4-4). 
 
 Because the cell fate commitment is completed after birth, we characterized the 
Notch1Cre (Low)/+; Rosa26-CAG-Tdtomatoloxp/+at P6. In each cochlea (n=3), we quantified 
the Tdtomato+ cells inside the organ of Corti, which include SCs (PCs and DCs) and 
HCs. Along the entire cochlea, only 10 ± 2 (n=3) HCs were Tdtomato+ occupying ~0.4% 
of the total Tdtomato+ cells, while 3075 ± 100 (n=3) were SCs, occupying ~99.6% of the 
total Tdtomato+ cells (Figure 4-4H). It further proves that during cochlear development, 
almost all cochlear progenitors experiencing Notch1 signaling develop into SCs but not 
HCs, and suggests that Notch1 signaling blocks the HC fate commitment and/or further 
differentiation.48 
 
 
4.4 Summary and Discussion 
 
 Our data suggests that the potential of Notch1 signaling in specifying sensory 
patches is transient and declines with maturation, which highlights the need for additional 
signals (i.e. Atoh1 overactivation in Chapter 5) for HC regeneration in mammals after 
birth. 
 
 
4.4.1 Lateral induction and lateral inhibition effects of Notch1 signaling  
 
 Notch1 signaling elicits lateral induction effects at early embryonic ages 
(E12~E14.5) when prosensory progenitors are being specified. At later embryonic ages 
(after E14.5), Notch1 signaling induces lateral inhibition effects when HC and SC  
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differentiation starts. The phenotypes observed in our CAGCreER+; Rosa26-NICDloxp/+ 
model can be explained by these two sequential but different effects. EGFP and NICD 
share the same cis-transcription element. Therefore, we defined NICD+ cells as EGFP+ 
cells and NICD– cells as EGFP– cells. Such a definition has been used in previous 
studies in other systems involving this Rosa26-NICDloxp/+ strain.13,15,107  
 
 Given the permissive cellular environment, NICD overactivation at ~E10.5 
induced new HCs in the EGFP+ patches. All new HCs were EGFP–, and some SCs were 
EGFP+. While the emergence of EGFP+ SCs can easily be explained by the prosensory 
promoting ability of Notch1 signaling, new EGFP– HCs and SCs should be generated by 
the communication between EGFP+ cells and EGFP– cells, known as the lateral 
induction effects of Notch1 signaling. In other words, single tamoxifen injection first 
transforms some non-sensory cells into prosensory progenitors (EGFP+). These EGFP+ 
prosensory progenitors in turn further trigger their neighboring non-sensory cells, which 
are not targeted by tamoxifen and are EGFP–, to turn on Notch1 signaling. It eventually 
leads to the transformation of these EGFP– cells into prosensory progenitors. Thus, with 
EGFP as a lineage tracer, new prosensory progenitors can be divided into EGFP+ and 
EGFP– groups. EGFP– progenitors can differentiate into HCs or SCs. The final cell fate 
of each EGFP– progenitor might be mediated by Notch1 signaling among different 
EGFP– progenitors (here NICD from the endogenous Notch1 but not Rosa26 locus might 
be involved), referred to as lateral inhibition between HCs and SCs. In contrast, EGFP+ 
progenitors were prevented from committing into HCs because they constitutively 
expressed NICD (at the Rosa26 locus), and hence EGFP+ progenitors exclusively 
developed into SCs.    
 
 
4.4.2 Roles of Notch1 signaling in development of the cochlear neuronal lineage  
 
 Mouse inner ear neural and sensory progenitors are believed to originate from the 
Ngn1+ neural-sensory progenitors.101 This hypothesis, especially in the inner ear 
vestibular part, is further supported by the lineage tracing study with Ngn1CreER+; Z/EG 
mice102 and another study reporting that deletion of NeuroD1 leads to ectopic HCs in 
vestibular ganglia.103 However, despite cochlear SGNs being traced in Ngn1CreER+; Z/EG 
mice, cochlear prosensory progenitors were not, raising the question that whether 
cochlear SGNs and prosensory progenitors derive from the same neural-sensory 
progenitors.  
 
 The observation that delaminating neuroblasts (neural progenitors) express the 
Notch ligand Delta19 supports the idea that sensory progenitors are gradually specified 
among the neural-sensory progenitors by Notch1 signaling. In our study, presence of 
ectopic HCs in cochlear SGN regions of CAGCreER+; Rosa26-NICDloxp/+ embryos 
suggests that cochlear SGN progenitors with ectopic NICD are converted to prosensory 
progenitors, which can further differentiate into either HCs or SCs, even though we 
cannot rule out the possibility that some of the new HCs might originate from glia cells. 
In addition, defective Notch1 signaling by deleting Delta1 resulted in expanded neural 
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regions.16 Taken together, these results suggest that cochlear sensory progenitors and 
SGN progenitors originate from identical neural-sensory progenitors. 
 
 
4.4.3 Different dosages of Notch1 signaling activity during cochlear development 
 
 Series of studies have suggested that Notch1 signaling is induced in progenitors at 
early stage of cochlear development. An interesting question is why only 0.4% of HCs 
were traced with Tdtomato in our fate mapping analysis of  
Notch1Cre (Low)/+; Rosa26-CAG-Tdtomatoloxp/+ mice (Figure 4-4). There are at least two 
potential explanations; one is that SCs and HCs are indeed from two different progenitor 
pools that, however, are difficult to distinguish. The second is due to the different 
dosages of Notch1 expression levels (or Notch1 signaling) between the early (lateral 
induction stage) and late developmental stages (lateral inhibition). It is possible that 
Notch1 expression level in cochlear progenitors is too low to elicit efficient Cre-mediated 
recombination. However, Notch1 expression is upregulated in progenitors committing to 
SCs and efficient Cre-mediated recombination occurs. The different dosages of Notch1 
expression is now further supported by another recent report where Notch1 signaling is 
shown not necessary to specify cochlear progenitors.111 
 
 
4.4.4 Comparison of three different models explaining the induction of ectopic hair 
cells in mice  
 
 Besides our CAGCreER +; Rosa26-NICDloxp/+ model, two other mouse genetic 
models have been recently used to show that overactivation of NICD can induce the 
generation of ectopic HCs.13,15 These three models complement each other to provide 
evidence of Notch1 signaling activities in the developing mouse inner ear.  
 
 The advantage of the Pan et al. model13 is that it combines the mouse Cre/loxp 
and Tet-On genetic systems.112 NICD is transiently overactivated so that only lateral 
induction of Notch1 signaling is augmented and subsequent lateral inhibition is intact. 
Thus, ectopic prosensory progenitors can become either HCs or SCs. This model is 
different from our model in the following ways: 1) ectopic HCs can be found in cochlear 
SGNs regions across the entire turns in our model (Figure 4-1) but exclusively in basal 
turns in the Pan et al. model; 2) ectopic HCs can be found in the cochlear ventral part in 
our model (Figure 4-1) but in the dorsal part only in the Pan et al. model; 3) our data 
show that not all cells (~ E10.5) respond to NICD and become prosensory progenitors, 
but all cells seem to do so in the Pan et al. model. These differences may arise because 
different non-sensory cells were targeted: all cells were randomly targeted in our model, 
whereas Col2a1Cre activity determined the scope of the targeted cell population in the 
Pan et al. model.  
 
 The Hartman et al. model15 is similar to ours in that NICD is constitutively 
overactivated. The tamoxifen-independent hGFAPCre bypassed the dystocia problem 
encountered in our model, thereby allowing the analysis of adult/juvenile inner ears. In 
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the Hartman et al. model, presence of ectopic HCs at adult ages suggests that they can 
survive for a long time and are possibly functional. However, hGFAPCre will 
overactivate NICD soon after Cre is active and this model can therefore not be used to 
induce Notch1 signaling at various ages. Our tamoxifen-dependent CAGCreER+ allowed 
the overactivation of NICD at E10.5, E13 and P0/P1, in which we were able to show that 
there is an age-dependent decrease in the responsiveness of inner ear non-sensory cells to 
Notch1 signaling.  
 
 
4.4.5 Implication of Notch1 signaling in HC regeneration in mammals 
 
 Similar to the chick inner ear study,20 our study and two other reports13,15 show 
that either constitutive or transient overactivation of NICD can induce ectopic HCs in 
mice. These results can have significant implications on studies of HC regeneration after 
HC damage in mammals. The non-sensory cells adjacent the endogenous sensory 
epithelium might be good candidates for manipulating Notch1 signaling. 
 
 Not all EGFP+ patches contain ectopic HCs and only embryonic non-sensory 
cells respond to NICD overactivation and generate new HCs, which highlights that other 
factors or signals besides Notch1 signaling may be needed to generate a bona fide 
sensory epithelium permissive for mechanosensory HC formation. Consistent with these 
data, Notch1 signaling has been shown to be required to maintain but not to initiate 
prosensory patch formation.113 Although these factors have yet to be identified, previous 
studies have shown that during cochlear morphogenesis, Fgfr114,115 and Wnt116,117 
signaling pathways are involved in patterning the prosensory area. It is possible that a 
combined modulation of these signals triggers the conversion of postnatal non-sensory 
cells to HCs. 
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CHAPTER 5.    ECTOPIC ATOH1 REPROGRAMS SUPPORTING CELLS INTO 
HAIR CELLS 
 
 
5.1 Introduction 
 
 Reprogramming one cell type into another after cell damage is an effective 
approach used in regenerative medicine.118 The landmark study where four key 
transcription factors can successfully reprogram somatic fibroblast cells into pluripotent 
embryonic stem cells highlights the concept that individual cell fate and function is 
mainly determined by combinations of different lineage specific transcription factors.119 
This concept was further supported by a series of studies including reprogramming 
fibroblasts into neurons,120 cardiomyocytes121 and reprogramming pancreatic exocrine 
cells into their lineage-related insulin producing beta cells122 by overexpressing different 
specific linage transcription factors. Such lineage reprogramming therefore establishes a 
general basis for regenerative medicine including how to regenerate auditory hair cells 
(HCs) after HC damage to heal human deafness. 
 
 Atoh1 has been suggested to be a good candidate gene to define the HC fate, and 
possibly used for HC regeneration in mammals. In vitro overexpression of Atoh1 in the 
non-sensory GER region of neonatal rat cochlear explants generates ectopic HCs,43 which 
supports the sufficiency of Atoh1 in specifying a HC fate in a permissive cellular 
environment. In vivo overactivation of Atoh1 in mouse otocysts41 and in adult cochleae of 
guinea pig42 also leads to ectopic HCs.  
 
 Unfortunately, in these studies Atoh1 was overactivated in all cell types, making 
it impossible to determine, at single cell resolution, whether each individual ectopic HC 
is born from the endogenous HC lineages or from the SC lineage. Also, it remains elusive 
whether these ectopic HCs express prestin, a terminal differentiation marker responsible 
for the cochlear amplifier.123,124 Moreover, it is undetermined which SC subtype within 
the organ of Corti can give rise to inner or outer HCs. In addition, it is unclear whether 
constitutive or transient Atoh1 overexpression is required for in vivo reprogramming of 
SCs into HCs. Finally, it is unclear whether postmitotic mouse SCs at different postnatal 
ages still respond to ectopic Atoh1 expression and can be reprogrammed into HCs.   
 
 To induce ectopic Atoh1 expression at different developmental stages, we 
generated a CAG-flox-stop-flox-Atoh1-HA+ (hereafter named as Atoh1-HA+) transgenic 
mouse model. By crossing Atoh1-HA+ mouse line with different SC specific CreER 
mouse lines (i.e. PlpCreER+, Prox1CreER+ or Fgfr3iCreER+), ectopic Atoh1 expression is 
induced in SCs specifically at different postnatal ages, permitting single cell resolution 
analysis. 
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5.2 Materials and Methods 
 
  
5.2.1 Mouse strains  
 
 The Atoh1-HA+ transgenic  mouse line was generated  with the following steps: 
1) the Atoh1-HA construct was designed by creating primers that attached two HA tags 
to the 3’ end of the pGEM-T-EASY Atoh1 from Dr. Martine Roussel’s laboratory in St. 
Jude Children’s Research Hospital; 2)  It was then put back into the PGEM-T-EASY 
Vector; 3) Not I restriction enzyme was used to cut out the Atoh1-HA;  3) The vector 
pCAGGS-loxp-stop-loxp-IRES-GFP (from Dr. Tyler Jacks’s laboratory in Massachusetts 
Institute of Technology) was also digested with Not I to remove the IRES-GFP; 4) the 
Atoh1-HA was then ligated into the pCAGGS-loxp-stop-loxp vector. The final size of the 
fragment after the backbone was digested out with Sal I was 4.8 Kb.   
 
 PlpCreER+ mice were purchased from Jackson Laboratory (USA). Prox1CreER/+ 
mice were kindly provided by Dr. Guillermo Oliver’s laboratory in St. Jude Children’s 
Research Hospital. Fgfr3iCreER+ mice were kindly provided by Dr. William Richardson’s 
laboratory in the University College London (UK). CAG-loxp-stop-loxp-EGFP+ reporter 
mice were kindly provided by Dr. Jeffrey Robbins’s laboratory in the Cincinnati 
Children's Hospital Medical Center. Atoh1-EGFP+ mice were kindly provided by Dr. 
Jane Johnson’s laboratory in the University of Texas Southwestern Medical Center. 
 
 
5.2.2 Antibodies and reagents 
 
 With the same experimental procedures described in Chapter 2, the following 
antibodies were used: anti-Myosin-VI (rabbit, 1:200, 25-6791, Proteus Bioscience), 
anti-Calbindin (rabbit,1:500, AB1778, Millipore), anti-Parvalbumin (mouse, 1:2000, 
P3088, Sigma), anti-HA (rat, 1:100, 11867431001, Roche), anti-Prestin (goat, 1:200, 
sc-22692, Santa Cruz Biotechnology), anti-Lhx3 (rabbit, 1:2000, AB3202, Millipore), 
anti-GFP (chicken, 1:1000, ab13970, Abcam), anti-Sox2 (goat, 1:1000, sc-17320, Santa 
Cruz Biotechnology), anti-espin (a gift from Dr. Stefen Heller in Stanford University). 
The following secondary antibodies from Invitrogen Company were used: chicken 
anti-rat Alexa Fluor 488 (A-21470), goat anti-rat Alexa Fluor 568 (A11077), goat 
anti-rabbit Alexa Fluor 647 (A21245), donkey anti-rabbit Alexa Fluor 647 (A31573), 
donkey anti-goat Alexa Fluor 568 (A11057), goat anti-rabbit Alexa Fluor 568 (A11036), 
goat anti-mouse Alexa Fluor 647 (A21236) and goat anti-chicken Alexa Fluor 488 
(A11039). All different secondary antibodies were used as 1:1000 dilutions. All images 
were taken with a confocal microscope (Zeiss LSM 700).  
 
 
5.2.3 Quantification of newly generated hair cells  
 
 The cochlear samples are cut into three parts. After scanning each part with a 
confocal microscope at 10 × lens, we measured the total length of the cochleae. Then, 
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each cochlea was divided into three turns (basal, middle and apical) with equal length. 
For the Prox1CreER/+; Atoh1-HA+ model, because of the limited number of new HCs, 
each entire cochlea was Z-stack scanned with 40 × lens (1µm interval). For Fgfr3iCreER+; 
Atoh1-HA+ model, because there were many new HCs with relatively even distribution 
across the cochlear turns, two regions at each turn were randomly chosen and an 
averaged HC number was calculated in each sample. For the PlpCreER+; Atoh1-HA+ 
model, the new HCs across the entire cochlear turns were quantified at P6 when only a 
few new HCs were present. Two regions at each turn were randomly chosen and an 
averaged HC number was calculated in each sample at P22 or P60 when many new HCs 
were present and their distribution was even. 
 
 
5.3 Results 
 
 
5.3.1 Generation of inducible Atoh1 overexpressing mouse lines 
 
 Atoh1 is normally undetectable in SCs at postnatal ages.39,40 Here, we focused on 
three subtypes of SCs, inner phalangeal cells (IPHs), Pillar cells (PCs) and Deiters’ cells 
(DCs) that are directly underneath the endogenous HCs, with the belief that they are good 
sources to regenerate HCs in situ (Figure 5-1A). To reactivate Atoh1 in postnatal IPHs, 
PCs and DCs, we generated inducible Atoh1-HA+ transgenic mouse lines in which Atoh1 
(tagged with HA at the C-terminus) is driven by the CAG promoter but its expression is 
blocked until the “STOP” fragment is deleted in a Cre-mediated manner (Figure 5-1B). In 
addition, HA tag does not affect the activity of Atoh1, as wild type cerebellum granule 
neuronal progenitors (GNPs) transfected with retroviruses expressing the same 
HA-tagged Atoh1 and Gli1 led to medulloblastoma twice as rapidly as GNPs transfected 
with retroviruses expressing Gli1 alone (unpublished observation from Dr. Martine 
Roussel’s laboratory), when they are orthotopically transplanted into the cortex of 
CD1-nu/nu recipient mice.125  
 
 We obtained four different transgenic founders after pronuclear injection of the 
transgenic construct. While all four founders (10, 11, 12 and 19) expressed ectopic 
Atoh1-HA expression in IPHs, PCs and DCs when crossed with different CreER mouse 
lines, lineage reprogramming of IPHs, PCs and DCs into HCs only occurred in founder 
10. Therefore we focused on the founder 10 for subsequent analyses.  
 
 
5.3.2 Neonatal inner phalangeal cells (IPHs) can be reprogrammed into inner hair 
cell-like cells 
 
 Analysis of PlpCreER+; Rosa26-LacZloxp/+ mice showed that Cre activity is limited 
to IPHs inside the organ of Corti.126 We also independently analyzed PlpCreER+; 
Rosa26-EYFPloxp/+ mice at P6 which were subjected to tamoxifen at P0 and P1. Inside the 
organ of Corti, most of the EYFP traced cells were IPHs, while a small fraction were PCs 
and DCs. EYFP+ HCs were never observed. Because there is no difference among  
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different cochlear turns, we grouped three turns together and normalized EYFP+ cells to 
the total number of each SC subtype. About 47.71% of IPHs were EYFP+, and 3.42% of 
PCs and 5.16% of DCs were EYFP+ as well (Figure 5-2). Because the majority of 
EYFP+ cells were IPHs, we used PlpCreER+ mice to determine whether ectopic Atoh1 can 
reprogram IPHs into HCs.  
 
 We crossed PlpCreER+ with Atoh1-HA+ mice to obtain PlpCreER+; Atoh1-HA+ mice 
as the experimental group, while PlpCreER - ; Atoh1-HA+ or PlpCreER+ ; Atoh1-HA– 
littermates were the control group. Both experimental and control groups received 
identical treatments: first with tamoxifen at P0 and P1, and second analysis at various 
ages. In our study, we used the HA antibody to label and visualize ectopic Atoh1 
expression. Permanent Atoh1-HA expression allowed us to perform lineage tracing of the 
Atoh1-HA+ PCs and DCs, and to further determine whether they could be reprogrammed 
into HCs by co-labeling Atoh1-HA and different HC specific markers. Many Atoh1-HA+ 
cells (830 ± 40, n=3) were observed across the entire cochlear turns at P6, among which 
2.5% of Atoh1-HA+ cells (20 ± 6, n=3) migrated up to HC layer and turned on 
Myosin-VI (Figure 5-1C-C’), which is the earliest marker to define a HC fate within the 
organ of Corti.127, 128 Intriguingly, the majority of the Atoh1-HA+/Myosin-VI– IPHs 
remained in the SC layer (Figure 5-1C’’).  
 
 When samples were analyzed at P22, however, there were much more 
Atoh1-HA+/Myosin-VI+ cells (153 ± 14, n=3) across the entire cochlea, occupying about 
18% of the total Atoh1-HA+ cells (851 ± 36, n=3) (Figure 5-1D-D’). The number of 
Atoh1-HA+/Myosin-VI+ cells was not further increased when samples were analyzed at 
P60 (Figure 5-1E). In addition, Atoh1-HA+/ Parvalbumin+/Lhx3+ (Figure 5-1F-F’’’) or 
Atoh1-HA+/Calbindin+/Prestin-negative cells (Figure 5-1G) were present across the 
entire cochlear turns. Calbindin and Parvalbumin are normally expressed in HCs but not 
SCs.129 Lhx3 is a transcriptional factor that is expressed during the HC differentiation 
process and genetic interactions among Lhx3, Pou4f3 and Atoh1 have been proposed 
previously.130, 131 It suggests that with ectopic Atoh1 expression some but not all IPHs 
can be reprogrammed into HC fate and turn on multiple HC specific markers, and that the 
reprogramming speeds are heterogeneous among different IPHs. Cells deriving from 
Cre+ IPHs and reactivated HC markers were tentatively defined as new HCs. 
Interestingly, the Atoh1-HA expression level in these HCs was always much higher than 
that in Atoh1-HA+ IPHs which did not reactivate HC specific markers (or were not 
successfully reprogrammed). While 43% of the new HCs lost Sox2 expression, 57% of 
them still maintained Sox2, suggesting a potential different extent of the reprogramming 
among HC-like cells. Lastly, in either of the control groups, we never  
saw HA+ cells nor ectopic HCs, confirming that our Atoh1-HA+ transgene was not 
expressed in the absence of Cre-mediated recombination. 
 
 The cilia structure on the top surface, referred as to stereocilia, is one of the 
characteristics of HCs. OHCs have the  “V” or “W” shaped stereocilia and IHCs have the 
straight line shaped stereocilia, which makes it possible to further determine whether the 
new HCs are OHCs or IHCs. We crossed CAG-flox-stop-flox-EGFP+ (hereafter 
CAG-EGFP+) mice132 with PlpCreER+; Atoh1-HA+ mice.  
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PlpCreER+; Atoh1-HA+; CAG-EGFP+ mice were treated with tamoxifen at P0 and P1 and 
analyzed at P9 (Figure 5-1H-H’). The actin-binding protein espin was used to visualize 
stereocilia.133 Expression of espin on the top surface of the EGFP+ cells clearly showed 
that the stereocilia was formed at P9 in these newly generated HCs (EGFP+, derived 
from Cre+ IPHs). Furthermore, the stereocilia morphology of the new HCs is very similar 
to that of the endogenous inner but not outer HCs. Consistently, these HC-like cells did 
not express prestin,123 an OHC specific marker (Figure 5-1G). It supports that IPHs-
derived HCs adopt the inner hair cell fate. 
 
 Presence of stereocilia in the new HCs prompted us to further determine whether 
they had the electrophysiological function of wild type HCs. The initial step of sensing 
sound starts at the opening of the mechanosensory transduction (MET) channel located in 
the stereocilia. Whole mount prepared cochlear epithelium of PlpCreER+; Atoh1-HA+ or 
PlpCreER+; Atoh1-HA+; CAG-EGFP+ were exposed transiently (30 second incubation 
only) to the FM4-64FX dye at P13, P30 and P90. We found that the FM4-64FX dye was 
taken up into Atoh1-HA+ or EGFP+ new HCs at all ages (Figure 5-1I-I’). Furthermore, 
when cochlear samples were treated with FM4-64FX dye and reagents interfering or 
blocking the MET channel, the intensity of FM4-64FX inside the Atoh1-HA+ or EGFP+ 
new HCs were either absent or dramatically decreased (Figure 5-1I-I’). Taken together, it 
suggests that the MET channel is present and presumably functional in the new HCs.  
  
 To determine whether these new HCs were innervated by spiral ganglion neuronal 
fibers, CtBP-2 was used to visualize the presynaptic ribbons.134 Presence of 
CtBP-2+/Atoh1-HA+/Calbindin+ cells strongly suggests that synapses are formed 
between HC-like cells and spiral ganglion neurons (Figure 5-1J-J’), which was further 
supported by the fact that Tuj1+ neuronal fibers were connected to these HC-like cells. 
Moreover, the distribution of CtBP-2 in the synaptic regions of these new HCs appeared 
punctate, similar to what was reported in inner HCs,134 again supporting that these 
IPH-derived HCs are functional inner HCs. Further conclusive experiments are needed to 
prove the functionality of IPHs-derived new HCs. 
 
 Last, because only very limited IPHs could be targeted when tamoxifen was 
injected at P12 and older ages, we did not analyze the response of the juvenile IPHs to 
ectopic Atoh1-HA expression. 
 
 
5.3.3 Ectopic Atoh1-HA reprogrammed neonatal pillar and Deiters’ cells to hair 
cells  
 
 To induce ectopic expression of Atoh1-HA specifically in neonatal PCs and DCs, 
we crossed Prox1CreER/+ mice with Atoh1-HA+ mice. The Cre activity of Prox1CreER/+ was 
limited to PCs and DCs when tamoxifen was given at P0 and P1.73 Prox1CreER/+; 
Atoh1-HA+ mice were experimental groups, while Prox1CreER/+; Atoh1-HA– or Prox1+/+; 
Atoh1-HA+ mice were used as control groups. All experimental and control mice from 
the same litters received the same tamoxifen treatment at P0 and P1. Similar to PlpCreER+; 
Atoh1-HA+ mouse models, we used HA antibody to label and visualize ectopic 
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Atoh1-HA expression. Consistent with the graded Cre activity of Prox1CreER/+  in 
different turns,73 ~5% of PCs and ~16% of DCs were Atoh1-HA+ in apical turns, while 
~3% of PCs and ~7% of DCs were Atoh1-HA+ in middle and basal turns of Prox1CreER+; 
Atoh1-HA+ mice at P6. Again, permanent Atoh1-HA expression allowed us to perform 
lineage tracing of the Atoh1-HA+ PCs and DCs, and to further determine whether they 
could be reprogrammed into HCs by co-labeling Atoh1-HA and different HC specific 
markers. 
 
 We analyzed samples at P6, P12, P22, P60 and P90. P22 is the earliest age when 
we could find Atoh1-HA+/Myosin-VI+, Atoh1-HA+/Calbindin+ and 
Atoh1-HA+/Parvalbumin+ cells (Figure 5-3A-C). These cells expressing Atoh1-HA 
(derived from PCs or DCs) and multiple HC markers were defined as new HCs at single 
cell resolution. The number of new HCs per cochlea was much higher at P60 (30 ± 6, 
n=3) than P22 (12 ± 2, n=3) (Figure 5-3D). The number of new HCs was not further 
increased at P90. This supports the idea that different PCs and DCs will take different 
times to be reprogrammed. Similar to the IPHs derived new HCs, Atoh1-HA expression 
level in the new HCs always seemed much higher than the Atoh1-HA+ PCs and DCs that 
did not reactivate multiple HC markers (Figure 5-3E-E’). These new HCs migrated to the 
HC layer and resided in OHC regions, causing cell death of endogenous OHCs. Among 
the total Atoh1-HA+ PCs and DCs at P60 or P90, 6% ± 2% (n=3) can be reprogrammed 
into HCs. 
 
 To determine whether the new-HCs could be fully differentiated, we further 
performed double labeling of Atoh1-HA and prestin, which is a terminal differentiation 
marker for OHCs and required for the cochlear amplifier.123, 124 All the new HCs did not 
express prestin at P22 (Figure 5-3A-A’) or P90 (data not shown), suggesting they are not 
fully differentiated. To confirm our data, we further analyzed the Prox1CreER/+; 
Atoh1-HA+; CAG-EGFP+ mice at P30 (n=3) or P60 (n=3). Espin is an actin binding 
protein highly expressed in HC stereocilia. Absence of the EGFP+/Espin+ cells suggests 
that there were no obvious stereocilia in the surface of the new HCs (Figure 5-3F). In 
addition, their overall round morphology suggests that they are not properly polarized 
(Figure 5-3). Last, in neither of the control groups, did we observe Atoh1-HA expression, 
ectopic HCs or sporadic endogenous OHC loss. 
 
 
5.3.4 Juvenile pillar and Deiters’ cells with ectopic Atoh1-HA also can be 
reprogrammed to hair cells 
 
 Because human deafness can occur at any postnatal ages due to various ototoxic 
factors, it is of particular interest to determine whether juvenile PCs and DCs (at P6 and 
P7 or P12 and P13) that are in the process of differentiation can still respond to ectopic 
Atoh1-HA expression and be reprogrammed to HCs. As Prox1 declines rapidly after birth 
in mouse SCs,83 Prox1CreER/+ cannot be used to drive ectopic Atoh1-HA expression. We 
therefore used the Fgfr3iCreER+ mouse line. We analyzed Fgfr3iCreER+; Atoh1-HA+ mice, 
in comparison with Fgfr3iCreER+; Atoh1-HA – or Fgfr3iCreER- ; Atoh1-HA+ littermate 
controls. We analyzed Fgfr3iCreER+; Atoh1-HA+ mice one month (P36) after tamoxifen
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injection P6 and P7, or P42 when tamoxifen were given at P12 and P13. Because of the 
similar phenotypes between the two tamoxifen treatment schedules, here we only 
described in details the latter one. About 80% ± 5% (n=3) of the PCs and DCs were 
Atoh1-HA+. In the averaged 160 µm cochlear length, 11 ± 2 (n=4) 
Atoh1-HA+/Calbindin+ cells (defined as new HCs) were found in the OHC region at 
P42, which occupied approximately 11.7 % of the total Atoh1-HA+ PCs and DCs (Figure 
5-4A-A’’’). But none of the new HCs expressed prestin (arrows in Figure 5-4A-A’’’). 
Additionally, these new HCs also expressed Parvalbumin and Lhx3 (Figure 5-4B-B’’’). 
The juvenile PCs and DCs derived new HCs migrated to the HC layer, resulting in cell 
death of endogenous OHCs. As expected, in either control group, there were no 
endogenous OHC loss and no newly generated HCs. 
 
 Studies in other tissue cells support the notion that endogenous master cell fate 
determination genes need to be turned on for efficient reprogramming.122,135,136 To 
determine whether in the new HCs the external Atoh1-HA could turn on the endogenous 
Atoh1 at single cell resolution, Fgfr3iCreER+; Atoh1-HA+ mice were bred with the 
transgenic Atoh1-EGFP+ mice where EGFP is driven by Atoh1 enhancer.137 In 
Fgfr3iCreER+; Atoh1-HA+; Atoh1-EGFP+ mice that were treated with tamoxifen at P12 
and P13, EGFP was used to reflect the activation of endogenous Atoh1 due to the 
positive auto-regulation of Atoh1.138 In the averaged 160 µm cochlear length, 10 ± 4 
(n=3) EGFP+/Atoh1-HA+/Calbindin+ cells were found at P42 (Figure 5-5A-A’’’). 
Interestingly, Atoh1-HA+/Calbindin– PCs and DCs were EGFP– (Figure 5-5B-C’’’). The 
EGFP expression in endogenous HCs was faint that could only by detectable when the 
confocal laser had to be switched to a high power, in which condition EGFP signals in 
the Atoh1-HA+/Calbindin+/EGFP+ cells had been already oversaturated. 
 
 
5.3.5 Adult pillar and Deiters’ cells are insensitive to ectopic Atoh1-HA expression  
 
 We determined whether ectopic Atoh1 reprogrammed adult fully differentiated 
PCs and DCs into HCs. When Fgfr3iCreER+; Atoh1-HA+ mice were treated with 
tamoxifen once at P30, ~90% of PCs and ~50% of DCs were Atoh1-HA+ at P60. 
Surprisingly, we no longer observed HA+/Calbindin+ newly generated HCs or OHC loss 
(Figure 5-6A-C). We further analyzed mice at P90 and P120 and allowed Atoh1-HA+ 
PCs and DCs to have longer time to respond to Atoh1-HA expression (data not shown). 
Again, no new HCs were found. Consistently, 100% of Atoh1-HA+ PCs and DCs 
maintained expression of SC marker Sox2 (Figure 5-6D-D’’). Therefore, we concluded 
that fully matured PCs and DCs at P30 were not sensitive to ectopic Atoh1-HA 
expression. 
 
 Next we speculated that combination of prior OHC damage might promote adult 
PCs and DCs to respond to ectopic Atoh1-HA expression (Figure 5-6E). First, adult 
OHCs were damaged at P30 with Kanamycin and Furosemide.51 Second, OHC damage 
was further confirmed by auditory brainstem response (ABR) tests at P33, followed by 
tamoxifen injection once at P33. While there were many Atoh1-HA+ PCs and DCs, we 
did not find any new HCs and hearing impairment by drug damage was not improved 
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 when mice were analyzed one month later (P63) (Figure 5-6E-G’) or two month later 
(P83). Alternatively, to allow adult PCs and DCs to have ectopic Atoh1-HA before OHC 
damage, we also tried tamoxifen injection at P30, and performed drug damage three days 
later (P33). Again, neither new HCs were found nor hearing improvement was achieved. 
 
 
5.3.6 Permanent expression of Atoh1-HA in differentiating endogenous hair cells 
causes cell death  
 
 In the above models, ectopic Atoh1-HA expression is permanent. We found that 
PCs- and DCs-derived HCs may not be fully differentiated, even though multiple 
HC-specific genes were activated. This may be caused by the lack of additional unknown 
factors that are needed to fully reprogram PCs and DCs into mature HCs or that 
permanent Atoh1 expression prevents new HCs from completing terminal differentiation. 
While the former scenario remains an attractive idea to be explored in the future, we 
tested the latter by using the Gfi1Cre/+; Atoh1-HA+ mouse model, with the assumption 
that embryonic differentiating endogenous HCs (when Gfi1 is turned on) are similar to 
PC and DC-derived new HCs. Inside the organ of Corti, Cre activity in Gfi1Cre/+ mice 
starts at embryonic day (E) 15.5 and is specific to HCs;139 thus, in Gfi1Cre/+; Atoh1-HA+ 
mice differentiating endogenous HCs around E16 or E16.5 started to have both 
endogenous Atoh1 and ectopic Atoh1-HA expression in a basal to apical gradient.  
 
 We analyzed cochlear samples of Gfi1Cre/+; Atoh1-HA+ mice at P3, P14 and P35. 
All HCs were Atoh1-HA+/Myosin-VI+ and looked normal at P3 (n=3) (Figure 
5-7A-A’’’); however, at P14, ~60% of HCs were lost in the basal turn (n=3), while 
middle and apical HCs were normal except for the most apical region where varied OHC 
loss was present (Figure 5-7B-E’’’). The remaining IHCs were Atoh1-HA+/Calbindin+ 
and OHCs were Atoh1-HA+/Calbindin+/prestin+. When cochlear samples were analyzed 
at P35, ~98% of HCs in the middle or basal turns, and ~85% of HCs at the apical turn 
were lost (Figure 5-7F). Consistently, Gfi1Cre/+; Atoh1-HA+ mice were completely deaf 
at P35 by ABR test (Figure 5-7G). This finding suggests that permanent Atoh1-HA 
expression is not the main cause for absence of prestin expression in the newly generated 
HCs, that permanent Atoh1-HA expression is not ideal for HC regeneration and that 
mature, but not immature HCs are vulnerable to ectopic Atoh1-HA expression. However, 
it is also possible that new HCs may have their unique differentiation program.  
 
 
5.4 Summary and Discussion  
 
 We have achieved inducible ectopic Atoh1-HA expression specifically in three 
subtypes of postnatal cochlear SCs, IPHs, PCs and DCs, that reside directly underneath  
HCs within the organ of Corti. A fraction of neonatal or juvenile Atoh1-HA+ SCs were 
reprogrammed into HCs expressing HC markers (Myosin-VI, Calbindin, Parvalbumin, 
and Lhx3) and further survived for more than 3 months in vivo. The IPH-derived new 
HCs resembled the endogenous IHCs in many aspects. However, the newly generated 
HCs lacked Prestin expression and morphology of mature HCs, and remained at 
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intermediate differentiation stages without full differentiation into functional mature HCs 
(especially the OHCs). However, the adult PCs and DCs were insensitive to ectopic 
Atoh1-HA expression. We also tested permanent Atoh1 expression in endogenous 
embryonic HCs which resulted in death of only mature, but not in the immature HCs. 
Taken together, we propose that either transient Atoh1 expression or other factors in 
addition to Atoh1 are required to reprogram PCs and DCs (especially at adult ages) into 
fully differentiated functional HCs. 
 
 
5.4.1 Identifying the newly reprogrammed hair cells at single cell resolution 
 
 In the PlpCreER+ ; Atoh1-HA+ or Prox1CreER/+; Atoh1-HA+ model, because Cre 
activity is specific to SCs, we are therefore able to distinguish new SC-derived new HCs 
from the endogenous HCs by using Atoh1-HA expression as a lineage tracer. In addition, 
we always found that the Calbindin or Parvalbumin expression in newly reprogrammed 
HCs (especially those deriving from IPHs) at P60 was much higher than the adjacent 
endogenous HCs, which allowed us to definitively identify the new HCs. Indeed, the 
immuofluorescence of Calbindin or Parvalbumin in the new HCs had to be significantly 
oversaturated; otherwise it was hard to visualize their expression in the endogenous HCs. 
We speculated that the high level of Calbindin or Parvalbumin expression in new HCs 
might be caused by constitutive Atoh1-HA expression. 
 
 However, at juvenile ages, the iCre activity of Fgfr3iCreER+ mice is not absolutely 
specific to PCs and DCs (2% of OHCs are also iCre+); therefore there remains a very low 
chance that a few Atoh1-HA+/Calbindin+ cells might be endogenous OHCs. In each 160 
µm cochlear length, the number (11 ± 2, n=3) of Atoh1-HA+/ Calbindin+ cells was much 
higher than that of OHCs (1 ± 1, n=3) traced by reporter gene EGFP in the Fgfr3iCreER+; 
CAG-EGFP+ mice; Atoh1-HA+/Calbindin+/Prestin-negative cells in OHC regions 
should be derived from PCs or DCs, because endogenous OHCs should have Prestin at 
adult ages (unless endogenous OHCs somehow dedifferentiated or downregulated prestin 
by communicating with PCs or DCs with ectopic Atoh1-HA). Note that iCre activity of 
Fgfr3iCreER+also acted sporadically in a very small fraction of Hensen and Claudius cells. 
When we defined and quantified HCs, Atoh1-HA+/Calbindin+ cells (in LER region) 
laterally far away from the organ of Corti were not included. It remains possible that 
some Hensen and Claudius cell-derived Atoh1-HA+/Calbindin+ cells may migrate into 
the organ of Corti. 
 
 
5.4.2 Atoh1 dosage is a determinant factor for the hair cell fate  
 
 Although the Atoh1 gene is required in HC fate commitment and possibly in the 
differentiation process,38 not all Atoh1 expressing cochlear progenitors develop into HCs. 
36,37,40 However, in the Atoh1-EGFP+ transgenic mouse,137 EGFP is only detected in 
HCs. A simple explanation of the different results is that heterogeneous levels of Atoh1 
are present between progenitors and HC lineages (or progenitors who later on commit to 
HC progenitors). We therefore propose: 1) that, between E12.5 and E14.5, the 
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undifferentiated cochlear progenitors have lower levels of Atoh1, and Atoh1 turns on 
many target genes in progenitors that then permit further cell fate selections, as suggested 
in cerebellum tissues,140 and 2) that after E14.5, the Atoh1 level is somehow dramatically 
elevated in HC lineages which will irreversibly differentiate into HCs.39,40 
 
 Such a hypothesis is further supported by our data that only a small fraction of 
Atoh1-HA+ SCs turned on HC specific genes and most of the Atoh1-HA+ SCs kept SC 
fate. In addition, in either PlpCreER+; Atoh1-HA+; Atoh1-EGFP+ or Fgfr3iCreER+; 
Atoh1-HA+; Atoh1-EGFP+ mice, EGFP+/HA+/Calbindin+ newly generated HCs had 
high levels of EGFP expression (indicative of endogenous Atoh1 activation). However, 
Atoh1-HA+/Calbindin– SCs are EGFP–. The Atoh1-EGFP+ is a transgenic line in which 
only a portion of Atoh1 promoter region, is used to drive EGFP. The recently 
characterized knock-in Atoh1-EGFP mice141 might be required to solidify the 
endogenous Atoh1 expression pattern in the future. This result also supports that 
heterogeneous ectopic Atoh1 levels were detected in different Atoh1-HA+ cells. It might 
account for the fact that only a fraction of SCs could be reprogrammed into HCs, and 
supports the idea that there is a threshold for ectopic Atoh1-HA level to turn on 
endogenous Atoh1, only above which can reprogramming occur. It is also consistent with 
the fact that our other 3 Atoh1-HA transgenic founders cannot drive effective 
reprogramming. This may be due to the fact that they have overall lower levels of Atoh1 
expression related to genome insertion sites or copy numbers. 
 
 
5.4.3 Diverse reprogramming pathways among different supporting cells  
 
 In our PlpCreER+; Atoh1-HA+ model, the IPHs-derived HCs were adjacent (either 
medial or lateral) to the endogenous IHCs. In many aspects, they resembled the 
endogenous IHCs of the overall morphology of the entire cell body, shape of the 
stereocilia with the presence of MET channels, their innervations by spiral ganglia and 
characteristic patterns of ribbon synaptic structure and the presence of multiple HC 
markers. It remains elusive why IPHs-derived HCs prefer the IHC fate and we speculate 
that it might be correlated to their geographic proximity to spiral ganglion neurons. 
Furthermore, the reprogramming speeds appear different and unsynchronized among 
different Atoh1-HA+ IPHs, as the percentage of new HCs increases with post-induction 
time. It might highlight the heterogeneity among different IPHs. It is possible that the 
intrinsic differentiation state is different among IPHs, and the less mature IPHs will 
respond to ectopic Atoh1-HA more rapidly than the more mature ones. Alternatively, it is 
possible that various dosages of the initial ectopic Atoh1-HA (plus the potential different 
levels of endogenous Atoh1 that is turned on later) were present in Atoh1-HA+ IPHs, and 
that reprogramming is faster in cells with the higher net dosage of Atoh1. The various 
dosages of the initial ectopic Atoh1-HA might be caused by the heterogeneous CAG 
promoters among different IPHs or the different efficiency of Cre-mediated 
recombination (or different numbers of floxed stop fragments are deleted if multiple 
copies of transgene are present) or both. Actually, our southern blot results (by Atoh1 
probe) suggest multiple copies of the Atoh1-HA transgene. The more floxed “stop” 
fragments are deleted, the more copies of Atoh1-HA will be transcribed. 
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 In our Prox1CreER/+; Atoh1-HA+ model, we did not observe new HCs until P22, 
which was 16 days later than P6 when new HCs were first identified in PlpCreER+ ; 
Atoh1-HA+ model. Why is the reprogramming efficiency higher in the Atoh1-HA+ 
IPHs? We proposed 3 explanations: 1) The IPHs are more adjacent to GER region, and 
they might be less mature and more plastic than PCs and DCs; 2) Possible signals such as 
Notch and Fgfr signaling91 are present only in PCs and DCs but not in IPHs that can 
interfere with the efficiency of Atoh1 in reprogramming PCs and DCs; 3) As supported 
by the reporter assays, the Cre activity in PlpCreER+ is higher than Prox1CreER/+ mice. More 
floxed stop fragments can be deleted and more copies of Atoh1-HA will be transcribed, 
as discussed above. 
 
 
5.4.4 Effects of constitutive Atoh1 expression on hair cell differentiation  
 
 Atoh1 is believed to be expressed transiently during the HC differentiation 
process and fully differentiated adult HCs do not express Atoh1.39,40 Such a proposal is 
further supported by our Gfi1Cre/+; Atoh1-HA+ mice. Because the newly generated HCs 
in OHC regions were prestin-negative, we first predicted that constitutive overactivation 
of Atoh1 in embryonic differentiating HCs, especially in OHCs, would interfere with HC 
differentiation, with the hypothesis that constitutive Atoh1 expression blocks prestin 
expression.  
 
 In contrast, prestin was present in the surviving OHCs at P14, which suggests that 
absence of Prestin in new HCs, especially in Prox1CreER/+; Atoh1-HA+ or Fgfr3iCreER+; 
Atoh1-HA+, is not caused by constitutive Atoh1 expression. Instead, it is more likely that 
additional transcriptional factors are needed which can turn on Prestin. Nonetheless, the 
significant HC death in Gfi1Cre/+; Atoh1-HA+ at P35 clearly showed that constitutive 
Atoh1 expression is detrimental to the survival of adult HCs. Interestingly, the new HCs 
can survive till at least P90. Two explanations are proposed: 1) new HCs might not 
exactly follow the differentiation path (i.e. the global gene expression profiles) of the 
wild type HCs and somehow better tolerate the constitutive Atoh1; 2) Because in 
Gfi1Cre/+; Atoh1-HA+ model, cell death of HCs started from the basal turns (where HCs 
finish terminal differentiation first) and eventually most HCs died by P35, it is possible 
that only the adult fully differentiated HCs somehow can sense the aberrant Atoh1 
expression and die. If it is true, it is consistent with the notion that our newly generated 
HCs are not fully matured. Thus, they can survive in the presence of the constitutive 
Atoh1.  
 
 
5.4.5 Overactivating hair cell fate determining and differentiation genes in 
supporting cells for hair cell regeneration in mammals 
 
 Reprogramming one cell fate to another by overactivating key transcriptional 
factors is a general and powerful approach for regenerative medicine. SCs in the non-
mammalian vertebrates are the sources for regenerating HCs after HC damage occurs. 
Atoh1 is reactivated in the process of HC regeneration.6 To give mammals the capacity to 
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regenerate HCs, we tested the effects of constitutive overactivation of Atoh1 in postnatal 
SCs. Our data clearly supported the concept that high dosage of Atoh1 can reprogram 
SCs to adopt the HC fate without fully differentiation. Therefore, we proposed that high 
dosage of Atoh1 is sufficient to determine a HC fate but not to guide the entire process of 
HC differentiation. Identifying additional key transcriptional factors that control HC 
differentiation, especially which can turn on Prestin, will be informative to understand 
normal HC development and HC regeneration. Thus, combinational overexpression of 
Atoh1 and these key differentiation genes in SCs will likely generate new HCs which can 
be fully differentiated. 
 
 
5.5 Future Work 
 
 The data described in Figure 5-1 demonstrated that the new HCs derived from 
IPHs did resemble the endogenous IHCs in many aspects. Thus, one of the most 
important future work is to determine whether those new HCs are really functional. We 
plan to choose the highest criterion, which is to damage the endogenous IHCs prior to 
turning on Atoh1-HA expression in the neonatal IPHs, and then to determine whether 
those new HCs can compensate loss of the endogenous IHCs. 
 
 To achieve such a goal, we have recently characterized a new otoferlinCre/+ 
knock-in mouse line in which the otoferlin open reading frame is replaced by Cre 
(http://www.mmrrc.org/strains/32781/032781.html). By characterizing the otoferlinCre/+; 
CAG-EGFP+ reporter mouse line, the Cre activity starts to work at P1 and peaks around 
P11 (Figure 5-8). Almost all EGFP+ cells were IHCs at P1. Interestingly, much more 
EGFP+ IHCs could be observed in basal and middle turns than in apical turns (Figure 
5-8A-C). At P11, the distribution of EGFP+ HCs was similar among different turns, and 
~95% IHCs were EGFP+, and ~10% OHCs were EGFP+. The significantly enriched Cre 
activity in IHCs of otoferlinCre/+ mice allows us to use this line to damage the IHCs, while 
leaving OHCs intact.  
 
 PlpCreER+; otoferlinCre/+; Rosa26-loxp-stop-loxp-rtTA/+; TetO-DTA+; Atoh1-HA+ 
mouse line will be used as experimental group to test the functionality of the new HCs 
deriving from IPHs, while PlpCreER+; otoferlinCre/+; Rosa26-loxp-stop-loxp-rtTA/+; 
TetO-DTA+ mouse line will be used as control group. As illustrated in Figure 5-9, we 
planned to give Doxycycline containing food to both experimental and control group at 
~E16 or E18 (precise time will be finalized after further preliminary experiments). Then, 
doxycycline containing food will be stopped for 3 days (hopefully doxycycline 
concentration can be decreased below the working threshold within 3 days), after which 
mice will be treated with tamoxifen around P3 and P4 (to turn on Atoh1-HA) and their 
hearing capacities will be determined by our ABR measurement. If those new HCs are 
functional, the experimental group mice should have better hearing ability than the 
control group. 
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CHAPTER 6.    PROSPECTIVE FOR MAMMALIAN HAIR CELL 
REGENERATION 
 
 
6.1 Introduction 
 
 Our data described in previous chapters provide foundations for mammalian hair 
cell regeneration. To mimic the HC regeneration mechanism used in non-mammalian 
vertebrates, inactivation of either Sox2 or p27Kip1 can be used to induce SC subtypes to 
proliferate, and ectopic expression of Atoh1 can be utilized to reprogram SCs into HCs. It 
is worthy to emphasize that both scenarios only occur in mouse cochleae at young ages, 
but not adult ages. Unfortunately, it remains unclear why adult SCs become insensitive to 
the manipulation of Sox2, p27Kip1 and Atoh1. Furthermore, the neonatal or juvenile ages 
in mice correspond to the end of the first trimester/beginning of the second trimester, or 
within the second trimester of human embryogenesis, respectively. The comparison 
between mice and human is based on the information of website 
(http://www.translatingtime.net/). Briefly, the translational information is built on the 
Finlay/Darlington model,142, 143 in which three factors, species factor, neural events factor  
and primate factor, are used to adjust the differences among different species (primates or 
non-primates), or different organs (cortical regions, limbic systems and non-cortical, 
non-limbic regions). The primate factor only applies to primates (0.248683 for cortical 
event, and -0.079280 for limbic event). Therefore, it is critical to study how to achieve 
reprogramming of adult mouse SCs to HCs, and to figure out why the adult SCs have 
declined proliferative capacities. Our final goal of will be to heal human deafness which 
primarily occurs at postnatal ages by various kinds of ototoxic factors. 
 
 
6.2 Conversion of Adult Cochlear Cells into Young and Plastic Ages 
 
 With the advancement of cellular differentiation, each individual cell becomes 
committed to their own gene expression and unique functions. The mechanisms 
underlying these changes along the cellular maturation process are referred as to 
epigenetic. Developmental ages in many cases determine the cellular responses to 
overactivation or inactivation of genes, which is further supported by the recent studies in 
hematopoietic 144 or pancreatic cell lineages.145 While the detailed mechanism underlying 
the different reprogramming efficient of the same lineage at different ages remains 
unclear, distinct status DNA acetylation or methylation is suggested to play critical 
roles.146, 147 
 
 In terms of how to achieve the goal of reprogramming the adult cochlear SCs into 
HCs for mammalian HC regeneration, as suggested by recent studies in the regenerative 
medicine field,144 one applicable approach is in vivo overactivating the four iPS (induced 
pluripotent stem cells) factors into the adult SCs (P30).148 As shown in Fig. 6, if adult 
SCs with ectopic expression of the four iPS factors respond to Atoh1 overactivation and 
are reprogrammed into HCs, it will suggest that the four iPS factors are sufficient to 
convert adult cochlear SCs into the neonatal or juvenile ages that normally respond to the 
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overactivation of Atoh1. This is clearly of particular interest in adult human HC 
regeneration that mainly occurs at aged human. In addition, it also will provide a great 
model to further figure out the epigenetic changes in adult SCs between with and without 
overactivation of four of iPS factors. However, currently there is no direct evidence to 
suggest why the adult SCs, compared with neonatal and juvenile SCs, have significantly 
declined proliferative capacities. Further studies are needed that aim at elucidating the 
signaling pathways promoting the proliferation of SCs.  
 
 
6.3 Application of Mouse Pre-clinical Models to Humans  
 
 The goal of studies using genetically engineered mouse models is to provide pre-
clinical information for clinical medicine in humans. Different from mouse studies in 
which genome DNA sequence are altered for various purposes, the ideal way or treating 
deaf patients, besides cochlear explants transplantation, could be the use of small 
molecules-derived drugs. These drugs roughly can be categorized into two types. The 
first are drugs that can promote proliferation of cells including cochlear SCs. The second 
are the modifiers of chromatin structure, or drugs that promote transcription of HC 
specific genes, especially Atoh1. 
 
 Drugs that promote cell proliferation are beneficial for generating new HCs, but 
on the other hand, they are tumorigenic especially in the fast growing organs such as 
intestine and stomach. To avoid the systemic side effects, the best way would be   
transient local delivery through cochlear oval window exposed toward the middle ear. If 
systemic delivery is required for some drugs to be active (i.e. needs modifications by 
enzymes in liver), it might still be possible to transiently use them in patients whose 
deafness is triggered by chemotherapy to treat pre-existing tumors (i.e. children with 
ALL).   
 
 The second type of drugs ideal for converting human SCs into HCs should be able 
to reprogram adult mouse SCs into HCs, with consideration of the translational 
developmental events between mice and human. One type of drug here activates Atoh1 at 
the transcriptional level because Atoh1 normally is inactive in adult mouse SCs.39, 40  
To screen for such a drug in a high-throughput manner, mouse embryonic fibroblast cells 
(MEFs) isolated from Arf-/-; Atoh1EGFP/EGFP double mutant mice. Lack of Arf (alternative 
reading frame) tumor suppressor gene makes MEFs immotile, thus growing rapidly in 
vitro. Atoh1EGFP/EGFP is a knock-in mouse model in which the EGFP coding sequence is 
tagged at the 3’ end of Atoh1 gene.141 MEFs will be treated with different small 
molecules and turning on EGFP will indicate activation of Atoh1. Thus, EGFP will be 
used as read-out to judge what small molecules should be used in secondary assays in 
inner ear cells. Other drugs might be those that are able to promote efficiency of 
reprogramming. However, preliminary epigenetic comparison data between adult SCs 
with or without four ectopic iPS factors are needed, with the assumption that adult SCs 
with ectopic four iPS factors will respond to ectopic Atoh1 expression. These drugs 
might be modifier of chromatin structure.  
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